WO2012100100A2 - Slippery liquid-infused porous surfaces and biological applications thereof - Google Patents

Abstract

A self-healing, scratch resistant slippery surface that is manufactured by wicking a chemically-inert, high-density liquid coating over a roughened solid surface featuring micro and nanoscale topographies is described. Such a slippery surface shows anti-wetting properties, as well as exhibits significant reduction of adhesion of a broad range of biological materials, including particles in suspension or solution. Specifically, the slippery surfaces can be applied to medical devices and equipment to effectively repel biological materials such as blood, and prevent, reduce, or delay coagulation and surface-mediated clot formation. Moreover, the slippery surfaces can be used to prevent fouling by microorganisms such as bacteria.

Description

SLIPPERY LIQUID-INFUSED POROUS SURFACES AND BIOLOGICAL

APPLICATIONS THEREOF

RELATED APPLICATIONS

[0001] This application claims priority to U.S. Patent Application No. 61/434,217, filed on January 19, 2011; U.S. Patent Application No. 61/466,352, filed on March 22, 2011; U.S. Patent Application No. 61/470,973, filed on April 1, 2011; U.S. Patent Application No. 61/496,883, filed on June 14, 2011; U.S. Patent Application No. 61/509,488, filed on July 19, 2011, U.S. Patent Application No. 61/529,734 filed on Aug 31 2011; U.S. Patent Application No. 61/538,100, filed on September 22, 2011, the contents of which are incorporated by reference herein in their entireties.

INCORPORATION BY REFERENCE

[0002] All patents, patent applications, and publications cited herein are hereby incorporated by reference in their entirety in order to more fully describe the state of the art as known to those skilled therein as of the date of the invention described herein.

FIELD OF THE INVENTION

[0003] The present disclosure relates generally to surfaces that prevent adsorption or deposition from fluids, solids, or mixtures of fluids and solids of biological origin, and uses thereof.

BACKGROUND

[0004] Current development of liquid-repellent surfaces is inspired by the self-cleaning abilities of many natural surfaces on animals, insects, and plants. Water droplets on these natural surfaces maintain a near-spherical shape and roll off easily, carrying dirt away with them. The water-repellency function has been attributed to the presence of

micro/nanostructures on many of these natural surfaces. These observations have led to enormous interest in the past decade in manufacturing biomimetic water-repellent surfaces, owing to their broad spectrum of potential applications, which range from water-repellent fabrics to friction reduction surfaces.

[0005] More specifically, synthetic liquid-repellent surfaces in the art are inspired by the lotus effect (Barthlott, W. & Neinhuis, C. Purity of the sacred lotus, or escape from contamination in biological surfaces. Planta 202, 1-8 (1997)) in which water droplets are supported by surface textures on a composite solid/air interface that enables water droplets to easily roll off the surface (Cassie, A. B. D. & Baxter, S. Wettability of porous surfaces. Trans. Faraday Soc. 40, 0546 - 0550 (1944); Cassie, A. B. D. & Baxter, S. Large contact angles of plant and animal surfaces. Nature 155, 21-22 (1945)). However, this approach has inherent limitations that severely restrict its applicability. First, trapped air is a largely ineffective cushion against organic fluids or complex mixtures that, unlike water, have low surface tension that strongly destabilizes suspended droplets (Shafrin, E. G. & Zisman, W. A. Constitutive relations in the wetting of low energy surfaces and the theory of the retraction method of preparing monolayers. J. Phys. Chem. 64, 519-524 (I960)).

[0006] Moreover, air trapped within surface textures cannot withstand pressure, so that liquids - particularly those with low surface tension - can easily penetrate the surface texture under even slightly elevated pressures or upon impact, conditions commonly encountered with driving rain or in underground transport pipes (Nguyen, T. P. N., Brunei, P., Coffmier, Y. & Boukherroub, R. Quantitative testing of robustness on superomniphobic surfaces by drop impact. Langmuir 26, 18369-18373 (2010)). Furthermore, synthetic textured solids are prone to irreversible defects arising from mechanical damage and fabrication imperfections (Quere, D. Wetting and roughness. Annu. Rev. Mater. Res. 38, 71-99 (2008); Bocquet, L. & Lauga, E. A smooth future? Nature Mater. 10, 334-337 (2011)). Because each defect enhances the likelihood of the droplet pinning and sticking in place, textured surfaces are not only difficult to optimize for liquid mobility but inevitably stop working over time as damage accumulates. Recent progress in pushing these limits with increasingly complex structures and chemistries remains outweighed by substantial tradeoffs in physical stability, optical properties, large-scale feasibility, and/or difficulty and expense of fabrication (Tuteja, A. et al, Science 318, 1618-1622 (2007); Tuteja, A., et al, Proc. Natl. Acad. Sci. USA 105, 18200-18205 (2008); Ahuja, A., et al, Langmuir 24, 9- 14 (2008); Li, Y., et al, Angew. Chem. Int. Ed. 49, 6129-6133 (2010)).

[0007] Despite over a decade of intense research, surfaces in the art are still plagued with problems that restrict their practical applications: they exhibit limited oleophobicity with high contact angle hysteresis; fail under pressure; cannot self-heal when damaged; and are expensive to produce.

[0008] For example, no surfaces that delay or prevent blood clotting, a process that relies on adhesion of platelets and proteins to a surface as a first step, have been developed. Soluble anti-coagulants, such as heparin, must be added to flowing blood in any

extracorporeal shunt to prevent clot formation. Certain polymeric species, such as polyethylene glycol (PEG) chains, can influence the surface hydration layer to prevent protein adsorption and control blood clotting to a limited extent (Barstad, R.M, et al, Thrombosis and haemostasis 79, 302-305 (1998); Niimi, Y., et al, Anesth. Analg. 89, 573- 579 (1999); Chen, S. et al, Polymer 51, 5283-5293 (2010)). However, they are not fully effective and soluble anticoagulants still must be added to the blood.

[0009] Bacteria exist in their natural state predominantly as members of bio films - structured, multicellular communities adherent to surfaces in natural and anthropogenic environments. These communities are composed of many cells embedded within a polymeric organic matrix. Biofilm formation is of concern to industry and healthcare because it causes contamination of plumbing, oil wells, heat exchangers, building ventilation, food storage, medical implants, and other systems. Biofilms threaten human health by triggering an immune response, releasing harmful endotoxins and exotoxins, and clogging indwelling catheters; in fact, biofilms are responsible for nearly 100,000 nosocomial deaths annually in the United States and 80% or more of all microbial infections in humans.

[0010] Systemic and topical antimicrobial products have become extensively used to combat biofilm contamination in health care, agriculture, and industrial settings, and increasingly by the general public as well. Commercial products employ a wide variety of active chemical agents, or biocides, often delivered in liquid form and sometimes as vapor. One review of antiseptics and disinfectants identifies 12 classes of liquid agents and 5 common types of vapor-phase sterilants. Regardless of the particular chemistry or mechanism, biocides must be able to reach the target cell to cause damage. At the multicellular level, therefore, the effective biocide must penetrate into the extracellular matrix (ECM)— the slime-like "cement" of biofilm. Biofilms, however, offer their member cells protection from environmental threats. It has been reported that ECM acts as a diffusion barrier and as a charged binding filter for certain antibiotics, and that it complements enzymes and multidrug resistance pumps on cells that remove antimicrobials. The resistance to threats covers a wide range of treatments: biofilms exposed to chlorine bleach for 60 minutes are reported to still have live cells; biofilms in pipes continuously flushed over 7 days with multiple biocides recolonize the pipes, and biofilms have been reported to survive in bottled iodine solution for up to 15 months. Biofilms' resistance to antimicrobials may be related to the extreme nonwettability of their surface as well as resistance to vapor penetration.

[0011] Developing biomedical materials that are resistant to bio film formation before it causes damage or that prevent its robust attachment would significantly reduce the rate of nosocomial infections and the costs associated with treating them. Many negative effects of bacterial colonization stem from the formation of bio films as protective structures and the associated cooperative behavior of bacterial cells. Persistently bacteria-resistant materials are difficult to achieve by surface chemistry alone. Even if bacteria are unable to attach directly to a material, nonspecific adsorption of proteins or secreted surfactants to the surface eventually masks the underlying chemical functionality with a "conditioning film." These organic molecules will change the wettability and surface charge of the original surface, and after about 4 hours, a certain degree of uniformity is reached and the composition of the adsorbed material becomes material independent. Materials that rely on leaching impregnated antimicrobials such as silver ion (Ag+) for their function are furthermore limited by the finite reservoir of the active agent. Furthermore, the use of leaching paints containing copper or triorganotin to resist biofouling on ship hulls is increasingly prohibited because of their high environmental toxicity. Some recent research on the effects of nano- or microscale topographical features on bacterial adhesion and subsequent biofilm formation has suggested a possibly more persistent and environmentally sustainable form of controlling bacterial attachment to surfaces, but no evidence yet suggests that this approach can effectively prevent mature biofilm formation or attachment.

[0012] There exists a need for an inexpensive, chemically inactive, synthetic slippery surface capable of repelling fluids, withstanding high-impact pressure, and self-healing.

SUMMARY OF THE INVENTION

[0013] Disclosed herein are synthetic slippery liquid-infused porous surfaces ("SLIPS") for repelling fluids of biological origin.

[0014] In one embodiment, an article for repelling a biological material comprising a lubricating fluid layer is disclosed. The lubricating fluid layer is immiscible with the repelled biological material, and forms an ultra-smooth surface. In some embodiments, the lubricating fluid layer is stabilized in place by the underlying substrate. The article has a solid substrate on which the lubricating fluid adheres. The substrate is preferentially wetted by the lubricating fluid. The solid substrate and lubricating fluid form a slippery surface configured and arranged to contact a biological material.

[0015] In another embodiment, an article having a repellant surface is disclosed.

A lubricating fluid wets and adheres to a solid substrate comprising a roughened surface to form a stabilized liquid overlayer. The roughened surface and the liquid covering it have an affinity for each other such that the lubricating liquid is substantially immobilized on the substrate.

[0016] In another embodiment, a device capable of repelling a biological material comprising a lubricating fluid layer is disclosed. The lubricating fluid layer is immiscible with the repelled biological material, and forms an ultra-smooth surface. The device has a solid substrate on which the lubricating fluid adheres. The substrate is preferentially wetted by the lubricating fluid. The solid substrate and lubricating fluid form a slippery surface configured and arranged to contact a biological material.

[0017] In another embodiment, a method of preventing adhesion, adsorption, surface- mediated clot formation, or coagulation of a biological material is disclosed. The method comprises providing a lubricating fluid layer, wherein the lubricating fluid is immiscible with the biological material; providing a solid substrate, wherein the lubricating fluid adheres to the substrate to form a slippery liquid-infused surface; and contacting the biological sample to the surface.

[0018] In one or more embodiments, a method of making an article having a slippery surface is disclosed. A solid substrate is roughened and contacted with a lubricating liquid that forms a lubricating fluid layer. The roughened solid substrate and the lubricating layer form a slippery surface, and are configured and arranged for contact with a material that is immiscible with the lubricating liquid.

[0019] In another embodiment, an optically transparent device that prevents adhesion of biological material is disclosed. A roughened surface that is a transparent window is wetted by a lubricating fiuid that adheres to the roughened surface to form an over-coated layer. The roughened surface of the transparent window has a greater affinity towards the lubricating fluid as compared to a biological material. Moreover, the index of refraction of the lubricating liquid is substantially similar to the index of refraction of the roughened surface. The lubricating liquid and the biological material are substantially chemically inert with each other. In one or more aspects, the device is a biological sensor window.

[0020] In one or more embodiments, an article having a low adhesion surface for preventing or reducing biofilm attachment is disclosed. The article comprises a solid substrate having a roughened surface and a lubricating fiuid that adheres to and

preferentially wets the substrate to form a liquid upper surface. The liquid upper surface is configured and arranged to contact a biological material of interest. The lubricating fluid is immiscible with the biological material, and the biological material exhibits little or no adhesion to the article.

[0021] In any of the preceding embodiments, the following condition is satisfied:

7BXCOS( BX - 7AXCOS( AX > 0 (el), wherein ^AX is the interfacial energies of the biological material with a surrounding medium, and wherein }¾x is the interfacial energies of the lubricating fluid with the surrounding medium, and wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium, and wherein 6¾x is the equilibrium contact angle of the liquid of the lubricating fluid on a flat solid surface immersed under the surrounding medium.

[0022] In one or more embodiments, the following two conditions are satisfied when the article is exposed to Medium X, where X is air/gas/water/immiscible biological material: ?(yBxCOS< _Bx - 7AXCOS< AX) - 7AB > 0 (e2) and ?(yBxCOs6>Bx - 7AXCOS< AX) + 7AX - 7BX > 0 (e3), wherein ^AX is the interfacial energies of the biological material with a surrounding medium, y_Bx is the interfacial energies of the lubricating fiuid with the surrounding medium, ^AB is the interfacial energies of the biological material and the lubricating fluid interface, ΘΑ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium, 6½x is the equilibrium contact angle of the lubricating fluid on a flat solid surface immersed under the surrounding medium, and R is a roughness factor of the roughened surface.

[0023] In one or more aspects, the lubricating fluid prevents adhesion, coagulation, or clot formation of biological materials.

[0024] In the above embodiments, wherein the method further mediates inflammation, wound healing, plaque disposition, or foreign body response.

[0025] In the above embodiments, the method inhibits inflammation, wound healing, plaque disposition, or foreign body response.

[0026] In the above embodiments, the method prevents inflammation, wound healing, plaque disposition, or foreign body response.

[0027] In the above embodiments, the method further prevents bacterial contamination.

[0028] In one or more aspects, wherein the biological material is contacted with the surface at a fluid impact pressures is on the order of 10³-10⁷ Pa.

[0029] In one or more aspects, the surface is selected from the group consisting of a cannula, connector, catheter, needle, capillary tube, tubing, syringe and combinations thereof.

[0030] In one or more aspects, the surface is selected from the group consisting of a slide, plate, film, work surface, well, well plate, Petri dish, tile, jar, flask, beaker, vial, test tube, column, container, cuvette, bottle, drum, vat, tank, and combinations thereof.

[0031] In one or more aspects, the surface is selected from the group consisting of a clamp, skin hook, cuff, retractor, shunt, needle, capillary tube, tubing, and combinations thereof.

[0032] In one or more aspects, the surface is selected from the group consisting of an endotracheal tube, ventilator, associated ventilator tubing, drug delivery vehicle, syringe, endoscope, dialysis equipment, central veno-venous hemofiltration device, extracorporeal membrane oxygenation equipment, and combinations thereof.

[0033] In one or more aspects, the surface is selected from the group consisting of an organ, artificial organ, implant, and combinations thereof. [0034] In one or more aspects, the surface is selected from the group consisting of a biosensor, biological microelectromechanical devices (bioMEMs), bioelectrode, and combinations thereof.

[0035] In one or more aspects, the surface is a wound dressing.

[0036] In one or more aspects, the substrate is preferentially wetted by the lubricating fluid. In one or more aspects, the lubricating fluid infiltrates the substrate by capillary action.

[0037] In one or more aspects, the solid substrate is electrically conductive, non- conductive, magnetic, non-magnetic, elastic, non-elastic, light sensitive, or not light sensitive.

[0038] In one or more aspects, the solid substrate is silanized.

[0039] In one or more aspects, the substrate is a roughened surface comprising a porous material.

[0040] In the above embodiments, microparticles or nanoparticles are applied to a flat substrate to form a roughened, porous substrate.

[0041] In the above embodiments, microparticles or nanoparticles are applied to the substrate using photolithography, projection lithography, e-beam writing or lithography, depositing nanowire arrays, growing nanostructures on the surface of a substrate, soft lithography, replica molding, solution deposition, solution polymerization,

electropolymerization, electrospinning, electroplating, vapor deposition, layered deposition, rotary jet spinning of polymer nanofibers, contact printing, etching, transfer patterning, microimprinting, self-assembly, boehmite (γ-ΑΙΟ(ΟΗ)) formation, spray coated, and combinations thereof.

[0042] In one or more aspects, the substrate consists of a fluoropolymer.

[0043] In one or more aspects, the biological material is a fluid selected from the group consisting of whole blood, plasma, serum, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, and combinations thereof.

[0044] In one or more aspects, the biological material is a solution or suspension containing bacteria selected from the group consisting of Actinobacillus {e.g. , Actinobacillus actinomycetemcomitans), Acinetobacter (e.g., Acinetobacter baumannii), Aeromonas, Bordetella (e.g., Bordetella pertussis, Bordetella bronchiseptica, and

Bordetella parapertussis), Brevibacillus, Brucella, Bacteroides (e.g., Bacteroides fragilis), Burkholderia (e.g., Burkholderia cepacia and Burkholderia pseudomallei), Borelia (e.g., Borelia burgdorferi), Bacillus (e.g., Bacillus anthracis and Bacillus subtilis),

Campylobacter (e.g., Campylobacter jejuni), Capnocytophaga, Cardiobacterium (e.g., Cardiobacterium hominis), Citrobacter, Clostridium (e.g., Clostridium tetani or

Clostridium difficile), Chlamydia (e.g., Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psiffaci), Eikenella (e.g., Eikenella corrodens), Enterobacter, Escherichia (e.g., Escherichia coli), Francisella (e.g., Francisella tularensis), Fusobacterium,

Flavobacterium, Haemophilus (e.g., Haemophilus ducreyi or Haemophilus influenzae), Helicobacter (e.g., Helicobacter pylori), Kingella (e.g., Kingella kingae), Klebsiella (e.g., Klebsiella pneumoniae), Legionella (e.g., Legionella pneumophila), Listeria (e.g., Listeria monocytogenes), Leptospirae, Moraxella (e.g., Moraxella catarrhalis), Morganella, Mycoplasma (e.g. , Mycoplasma hominis and Mycoplasma pneumoniae), Mycobacterium (e.g. , Mycobacterium tuberculosis or Mycobacterium leprae), Neisseria (e.g., Neisseria gonorrhoeae or Neisseria meningitidis), Pasteur ella (e.g. , Pasteur ella multocida), Proteus (e.g., Proteus vulgaris and Proteus mirablis), Prevotella, Plesiomonas (e.g., Plesiomonas shigelloides), Pseudomonas (e.g., Pseudomonas aeruginosa), Providencia, Rickettsia (e.g., Rickettsia rickettsii and Rickettsia typhi), Stenotrophomonas (e.g., Stenotrophomonas maltophila), Staphylococcus (e.g., Staphylococcus aureus and Staphylococcus epidermidis), Streptococcus (e.g., Streptococcus viridans, Streptococcus pyogenes (group A),

Streptococcus agalactiae (group B), Streptococcus bovis, and Streptococcus pneumoniae), Streptomyces (e.g., Streptomyces hygroscopicus), Salmonella (e.g., Salmonella enteriditis, Salmonella typhi, and Salmonella typhimurium), Serratia (e.g., Serratia marcescens), Shigella, Spirillum (e.g., Spirillum minus), Treponema (e.g., Treponema pallidum), Veillonella, Vibrio (e.g., Vibrio cholerae, Vibrio parahaemolyticus, and Vibrio vulnificus), Yersinia (e.g., Yersinia enter ocolitica, Yersinia pestis, and Yersinia pseudotuberculosis), Xanthomonas (e.g., Xanthomonas maltophilia) and combinations thereof.

[0045] In one or more aspects, the biological material is a solution or suspension containing particles selected from the group consisting of a member of the genus

Aspergillus (e.g., Aspergillus flavus, Aspergillus fumigatus, Aspergillus glaucus, Aspergillus nidulans, Aspergillus niger, and Aspergillus terreus), Blastomyces dermatitidis, Candida (e.g., Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, and Candida guillermondii), Coccidioides immitis,

Cryptococcus (e.g., Cryptococcus neoformans, Cryptococcus albidus, and Cryptococcus laurentii), Histoplasma capsulatum var. capsulatum, Histoplasma capsulatum var. duboisii, Paracoccidioides brasiliensis, Sporothrix schenckii, Absidia corymbifera; Rhizomucor pusillus, Rhizopus arrhizous, and combinations thereof.

[0046] In one or more aspects, the biological material is a solution or suspension containing particles selected from the group consisting of normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, stem cells, and infected cells, microorganisms, viruses, virus-like particles, bacteria, bacteriophage, proteins, cellular components, cell organelles, cell fragments, cell membranes, cell membrane fragments, viruses, virus-like particles, cytosolic proteins, secreted proteins, signaling molecules, embedded proteins, nucleic acid/protein complexes, nucleic acid precipitants, chromosomes, nuclei,

mitochondria, chloroplasts, flagella, biominerals, protein complexes, and minicells.

[0047] In one or more aspects, the lubricating fluid is capable of self-healing by wicking back to the damaged region of the substrate after physical damage of the substrate to form an ultra-smooth surface.

[0048] In the above embodiments, a recovery time for self-healing occurs in less than 50 ms, 60 ms, 70 ms, 80 ms, 90 ms, 100 ms, 110 ms, 120 ms, 130 ms, 140 ms, 150 ms, 160 ms, 170 ms, 180 ms, 190 ms, 200 ms, 210 ms, 220 ms, 230 ms, 240 ms, 250 ms, 1 second, 5 seconds 10 seconds, 30 seconds, 60 seconds, 90 seconds, or 120 seconds or more.

[0049] In one or more aspects, the substrate has a plurality of holes, three- dimensionally interconnected network of holes and one or more materials, or random array of fibrous materials.

[0050] In one or more aspects, the substrate consists of a material selected from the group consisting of polymers, metals, sapphire, glass, diamond, graphite, black carbon, or ceramics. In one or more embodiments, the substrate is a hemocompatible material. In one aspect, the hemocompatible material is a silicon rubber or polysulfone.

[0051] In one or more aspects, the substrate is a polymer selected from the group consisting of polytetrafluoroethylene, polyvinylfluoride, polyvinylidene fluoride, and fluorinated ethylene propylene. [0052] In one or more aspects, the lubricating fluid has a density greater than the density of the biological material.

[0053] In one or more aspects, the lubricating fluid has a density greater than lubricating fluid has a density that is more than 1.0 g/cm³, 1.6 g/cm³, or 1.9 g/cm³.

[0054] In one or more aspects, the lubricating fluid comprises a fluid selected from the group consisting of tertiary perfluoroalkylamines,perfiuorotri-n-butylamine,

perfluoroalkylsulfides, perfluoroalkylsulfoxides, perfluoroalkylethers, perfluorocycloethers, perfluoropolyethers, perfluoroalkylphosphines, and perfluoroalkylphosphmeoxides, and combinations thereof.

BRIEF DESCRIPTION OF THE DRAWINGS

[0055] FIG. 1 is an image showing the structure of SLIPS, which is created by infiltrating a porous solid with a low surface energy, a chemically inert liquid that leads to a physically smooth and chemically homogeneous lubricating film on the surface of the substrate; the top and bottom scanning electron microscope (SEM) images FIG. l(i)-(ii) show ultra-smoothness of the lubricating fluid and a porous structure of the rough solid surface, respectively.

[0056] FIG. 2 is a schematic of a self-healing slippery surface in accordance with certain embodiments.

[0057] FIG. 3A-C shows time sequence images on the sliding motion of a droplet of hexane (yii_qui_d = 18.6 ± 0.5 mN/m, volume ~ 3.6 μί) along a SLIPS at low sliding angle (a = 3.0°) in accordance with certain embodiments.

[0058] FIG. 4 is a schematic comparing the partial wetting of a flat surface (FIG. 4A) and the complete wetting of a nanostructured surface in accordance with certain

embodiments (FIG. 4B).

[0059] FIG. 5A is a schematic of a structured surface with raised features over which the slippery surface is formed in accordance with certain embodiments.

[0060] FIG. 5B is a schematic of a columnar porous material over which the slippery surface is formed in accordance with certain embodiments.

[0061] FIG. 5C is a schematic of an inverse opal porous material over which the slippery surface is formed in accordance with certain embodiments.

[0062] FIG. 5D is an image of a random network porous material over which the slippery surface is formed in accordance with certain embodiments. [0063] FIG. 6 shows (A) a scanning electron microscope image of the surface morphologies of a 3D porous solid; and (B) a replica of a slippery surface formed by infiltrating the 3D porous solid of 6A with lubricating fluid showing that the lubricating fluid overcoats the surface topographies, forming an ultra-smooth layer without asperity (e.g., average roughness on the order of or less than about 1 nm based on high resolution atomic force microscopy measurements, see inset (6C) as viewed at low (6B) and high (inset 6(D)) resolution in accordance with certain embodiments.

[0064] FIG. 7A shows several planar and non-planar surfaces over which the slippery surface can be formed in accordance with certain embodiments.

[0065] FIG. 7B shows SLIPS formed over a cylindrical solid core in accordance with certain embodiments.

[0066] FIG. 7C shows SLIPS formed on the sidewall of the interior of a tubing/pipe and the like in accordance with certain embodiments.

[0067] FIG. 7D shows SLIPS formed on the sidewall of both of the interior and exterior of a tubing/pipe and the like in accordance with certain embodiments.

[0068] FIG. 7E shows SLIPS formed on the Liquid-B-soaked porous tubing and the like in accordance with certain embodiments.

[0069] FIG. 8a-b shows a schematic of capillary refilling in accordance with certain embodiments.

[0070] FIG. 9A shows SLIPS coupled to a Liquid B reservoir that can replenish evaporating or removed Liquid B in accordance with certain embodiments.

[0071] FIG. 9B shows SLIPS formed inside a cylindrical tube with a Liquid B reservoir that can replenish evaporating or removed Liquid B in accordance with certain embodiments.

[0072] FIG. 9C shows SLIPS formed along the surface of an arbitrary shaped flow path coupled to a channel for replenishing evaporating or removed Liquid B in accordance with certain embodiments.

[0073] FIG. 9D shows images of showing the formation of the bottom substrate portion of FIG. 9C in accordance with certain embodiments.

[0074] FIG. 10 shows images of substrate structures and topologies that can be used to generate SLIPS surfaces; (A) open-cell bricks, (B) post arrays, (C) parallel grooves, (D) open porosity PTFE (ePTFE), (E) plasma-etched PTFE, and (F) sand-blasted

polypropylene (PP).

[0075] FIG. 11 shows sequential images of whole human blood without anticoagulants as it is pipetted onto PDMS (11 A) and the oil-infiltrated PTFE (11B) surfaces.

[0076] FIG. 12 is a series of images of control and test surfaces after exposure to 0.75 mL of blood flow, which show absorption of blood to the control surfaces (glass (12A),

PDMS (12B), dry PTFE (12C)) but no apparent absorption to the oil-infiltrated PTFE

(12D).

[0077] FIG. 13 shows optical (13A(i), 13B(i)) and scanning electron microscope (SEM, 13A(ii), 13B(ii)) surface analysis images of the control and oil-infiltrated PTFE samples from FIG. 11A and 11B in which all the control materials showed evidence of adhered, dried blood species (a mixture of cells, platelets, proteins, see (13 A)), while the oil-PTFE material (13B) showed no evidence of biological material.

[0078] FIG. 14 is a series of diagrams that show exemplary methods by which SLIPS surfaces can be roughened: by spraying or depositing a particulate matter on the substrate (14A); etching (14B); and by growing a nanostructured material on the surface of the substrate (14C).

[0079] FIG. 15 is a series of images showing the self-healing and optical transparency properties of SLIPS. 15A. Time-lapse images showing self-healing capability of SLIPS from a ~50 μιη-wide physical damage on a time scale on the order of 100 ms. 15B. Time- lapse images showing the restoration of liquid repellency of SLIPS after physical damage, as compared to a typical hydrophobic flat surface on which oil remains pinned at the damage site.

[0080] FIG. 16A Optical images showing enhanced optical transparency of an epoxy- resin-based SLIPS (left) as compared to significant scattering in the non-infused super hydrophobic nanostructured surface (right) in the visible light range. 16B. Optical transmission measurements for epoxy-resin-based SLIPS in the visible light range (400- 750 nm). 16C. Optical transmission measurements for Teflon-based SLIPS in the near- infrared range (800-2300 nm).

[0081] FIG. 17 is a series of images showing the omniphobicity and high pressure stability of SLIPS. Time sequence images comparing mobility of pentane droplets (^A = 17.2 ± 0.5 mN/m, volume ~ 30 μί) on a SLIPS and a super hydrophobic, air-containing Teflon porous surface. While pentane is repelled on the SLIPS, it wets and stains the traditional super hydrophobic surface.

[0082] FIG. 18 is a set of graphs showing the contact angle hysteresis as a function of surface tension of test liquids (indicated) on SLIPS and on an omniphobic surface. In the inset (18A), advancing and receding contact angles of a liquid droplet are denoted as ( _ad_v, and ( _rec, respectively. SLIPS 1, 2, and 3 refer to the surfaces made of 1) Teflon porous membrane, 2) array of epoxy posts of geometry 1 (pitch = 2 μιη; height = 5 μιη; and post diameter = 300 nm), and 3) array of epoxy posts of geometry 2 (pitch = 900 nm; height = 500 nm to 2 μιη; and post diameter = 300 nm), respectively. A plot (18B) showing the high pressure stability of SLIPS, as evident from the low sliding angle of a decane droplet (y^ = 23.6 ± 0.1 mN/m, volume ~ 3 μί) subjected to pressurized nitrogen gas in a pressure chamber. Error bars indicate standard deviations from at least seven independent measurements.

[0083] FIG. 19 is a series of images demonstrating low-tilt-angle sliding of

Pseudomonas aeruginosa (PA 14) bio film growth in 2 mL tryptone broth puddles incubated for 24 hours atop liquid slippery surfaces in accordance with certain embodiments.

[0084] FIG. 20 is a series of fluorescence microscopy images of Pseudomonas aeruginosa (PA 14) bacteria remaining on various slippery liquid surfaces after 2 mL of shaken culture was incubated for 24 hours on the surfaces and subsequently slid off by applying a tilt angle in accordance with certain embodiments.

[0085] FIG. 21 show a toxicity screening of a number of commercially available products that can satisfy the requirements for the lubricating fluid in accordance with certain embodiments.

[0086] FIG. 22 is a schematic illustrating the whole wall of a catheter with SLIPS

(22A) and a catheter lined with a dense, nonporous material and SLIPS (22B).

[0087] FIG. 23 is a schematic of a wound dressing with SLIPS.

[0088] FIGS 24A to 24E show the different morphologies that can arise by changing the electrodeposition parameters in accordance with certain embodiments.

[0089] FIG. 25 is a graph showing the dependence of liquid repellency of SLIPS on the viscosity of Liquid B (here, Krytox 100, 103, and 105 (DuPont)). For constant viscosity of Liquid A (here, 25 μΐ, of glycerol), Liquid A's mobility increases as the viscosity of Liquid B decreases. Likewise, for constant viscosity of Liquid A, the mobility of Liquid A increases with reducing viscosity. Thus viscous dissipation plays a major role in the liquid mobility on SLIPS.

[0090] FIG. 26 shows images of whole human blood in non- wetting contact with SLIPS surfaces made with non perfluorocarbon lubricant liquids. Image (26A) shows a SLIPS surface generated using an infiltration of polydimethylsiloxane (PDMS) liquid (500 MW, X viscosity, OH-terminated, Sigma Aldrich) into an ePTFE membrane (1 μιη, Sterlitech). Image (26B) shows a SLIPS surface generated using an infiltration of olive oil into an ePTFE membrane (1 μιη, Sterlitech). In both cases the blood was found to not wet the surface, and rolled off without adhering to the surfaces.

[0091] FIG. 27A shows a schematic of a slippery surface having an over-coated Liquid

B formed over a roughened surface in accordance with certain embodiments.

[0092] FIG. 27B shows a schematic of a slippery surface with Liquid B infiltrated into the roughened surface in accordance with certain embodiments.

[0093] FIG. 28A-B shows images of the surface of the present disclosure

demonstrating self-healing properties, where the self-healing time scale is on the order of

100 ms in accordance with certain embodiments.

[0094] FIG. 29 is a chart showing restoration of liquid repellency function after critical physical damage (test liquid = decane, YLV = 23.6 ± 0.1 mN/m) in accordance with certain embodiments.

[0095] FIG. 30 shows images of non-anticoagulated whole human blood (diluted 1 : 1 with saline) flowing at 3,000 mL/hr using peristaltic pumping through SLIPS tubing for 20 min without producing clotting including the experimental setup (A) and results which showed no signs of clotting in the tubing (B).

[0096] FIG. 31A-C shows images of the tubing of FIG. 33 after 20 minutes of 12 mL of fresh human blood free of anticoagulant was pumped through SLIPS tubing. The blood did not clot in the tubing.

[0097] FIG. 32 is a graph showing the dependence of liquid repellency of SLIPS on the viscosity of Liquid B (here, Krytox 100, 103, and 105 (DuPont)). For constant viscosity of Liquid A (here, 25 of glycerol), Liquid A's mobility increases as the viscosity of Liquid A decreases. Likewise, for constant viscosity of Liquid B, the mobility of Liquid A increases with reducing viscosity. Thus viscous dissipation plays a major role in the liquid mobility on SLIPS. [0098] FIG. 33 shows images of ePTFE tubing (Zeus Inc) of increasing inner diameter (ID), from 0.075" to 0.236" (wall thickness is -0.040" for all) fit with an elastic, external, silicone tube casing (VWR) in low (A) and high magnification SEM of the porous ePTFE surface within the tubing (B).

[0099] FIG. 34 shows images of a transparent SLIPS surface, based on the infiltration of a highly-ordered nanoporous Si02 glass layer (A) with perfluorocarbon (FC-70) (B). When fully infiltrated the layer is highly transparent (C) and well suited for applications as a bio-sensor window.

[0100] FIG. 35 shows images of a process for fabricating a SLIPS tubing from ePTFE membranes.

[0101] FIG. 36 shows images (A-B) of surface typologies investigated with respect to bio film attachment properties. The remains of an evaporated drop of Pseudomonas aeruginosa biofilm-forming culture is shown on each surface, a superhydrophobic nanoporous PTFE surface (A) and a slippery liquid infused porous surface (SLIPS) (B). Biofilm grown on the PTFE and nanostructured superhydrophobic silicon substrates showed complete wetting of the surface and a slimy coffee ring. In contrast, biofilm on the SLIPS substrate cleanly retracted from the surface as it evaporated. The insets (i) and (ii) show fluorescence micrographs of remaining bacteria on these surfaces following 48 hour incubation of P. aeruginosa biofilm. The relative bacterial biofilm attachment was significantly less on PTFE-based SLIPS compared to the PEGylation surface (C).

[0102] FIG. 37 shows images of a macroscale view of biofilm attachment inhibition on SLIPS. Growth was conducted in a peristaltic pump at 10 mL/min (velocity ~1 cm/s) and dual-chamber 3D-printed flow cells with h = 1 mm, 1 = 10 cm, w = 1 cm channels. (A-B) Photographs of the control PTFE and SLIPS PTFE substrates after the flow cell was opened following 48 hour growth under 10 mL/min flow, both before crystal violet staining (top) and after (bottom). Equal-area samples of the substrates were eluted for crystal violet quantification, a measurement of attached biomass (C). Following 7 days of growth, crystal violet staining-based quantification showed a 99.6% reduction in attached biofilm on SLIPS versus control PTFE.

[0103] FIG. 38 shows images of a microscale view of P. aeruginosa biofilm attachment on SLIPS and control PTFE surfaces after 24 and 7-day growths in 10 mL/min flow. (A-B). Growth on the PTFE surface appeared dense, three-dimensional, and uniform (A-B), whereas on the SLIPS, only sparse, isolated single cells or microcolonies were observed (C-D). Referring to the graph, (E), these cells appeared to be unattached or poorly attached, i.e., drifting with convective currents in the fluid, further supporting that a liquid surface provides very low adhesion to the individual bacteria or micro-colonies.

[0104] FIG. 39 shows images and graphs that demonstrate that biofilm attachment reduction by SLIPS is species independent. The attachment of Staphylococcus aureus (A) and Escherichia coli (B), was reduced by 97.2% and 96%, respectively, versus PTFE following 48 hour growth under identical flow conditions to P. aeruginosa. While neither of these species formed as robust biofilms as does, their final attachment to SLIPS was comparably minimal(C-F). Visualized by fluorescence, dense uniform biofilm coverage and sparse, isolated cells respectively attached to the control and SLIPS substrates.

[0105] FIG. 40 is a set of images from a split- frame movie showing evaporation dynamics of P. aeruginosa culture droplets on a superhydrophobic PTFE porous surface (i- ii) and a PTFE SLIPS surface infused with Krytox 103 (iii-iv). The pinning characteristics as well as the stains remaining on the surfaces upon drying indicated the level of adhesion between the bacterial droplet and the substrate. In the absence of contact line pinning, the droplet follows a nearly constant contact angle mode of evaporation without the formation of a coffee ring stain (iv). The absence of the coffee ring formation also indicated that the adhesion of the bacteria on the SLIPS was small compared to the forces imparted by the meniscus of the droplet.

[0106] FIG. 41 shows images of a micro view of P. aeruginosa biofilm attachment on SLIPS and control PTFE surfaces after 24 and 48 hr growths in 10 mL/min flow, (a)

Fluorescence average intensities (b) average intensity graph showing a 97-98%) average intensity reduction, analogous to the crystal violet global measurement.

DETAILED DESCRIPTION OF THE INVENTION

[0107] Disclosed herein are synthetic slippery liquid-infused porous surfaces ("SLIPS") for repelling, preventing attachment, or reducing attachment of fluids ("Liquid A") or solids ("Object A") of biological origin. As referred to herein, Liquid A, Object A, and biological material are used interchangeably. Adhesion and absorption of material of biological origin are also reduced or prevented by SLIPS. [0108] SLIPS are synthetic surfaces that consist of nano/microstructured substrates infused with a lubricating fluid that is locked in place by a substrate to form a stable, defect-free, inert "slippery" interface capable of repelling complex fluids, gases, and molecules or particulates contained within liquids of varying surface tensions (together referred to as Liquid A), as well as solids. For example, liquids such as hydrocarbons, organic solvents, and the like can be repelled. The biological liquids refer to both pure liquids and complex fluids, such as blood flow (see, e.g., FIG. 11 and FIG. 12). As another example, solids like bacteria, proteins, and the like can be repelled by SLIPS. In addition, natural and synthetic solutions such as those used in medicines, intravenous solutions, pharmaceutical manufacturing, and medication delivery systems can be repelled by SLIPS.

[0109] The SLIPS consists of a porous surface layer, or a 'rough' layer of raised surface features in an array, which is infiltrated with a low surface energy liquid. The combination of lubricating fluid over a rough surface creates an ultra-smooth surface that is slippery and resists or reduces adhesion by particles and immiscible liquids. In some embodiments, the lubricating fluid is stabilized in place by the underlying substrate. In one or more aspects, the lubricating fluid is reduced to the level of the features of the substrate. These unique features of SLIPS allow the passage of biological material at high flow rates without permitting the material to form clots on, adhere to, attach, or otherwise foul SLIPS. SLIPS are also capable of restoring their exceptional liquid repellency when physically damaged. The fast self-healing times are a result of the lubricating fluid wicking fluid into damaged sites on the underlying substrate to restore SLIPS to a smooth defect-free surface. These surfaces can be used in laboratories, as a coating on medical devices and medical equipment, and for medical applications such as anticoagulation and anti-biofilm formation.

[0110] Generally, SLIPS can be manufactured by providing a liquid (e.g., chemically- inert, high-density fluid) over a roughened surface featuring micro- or nanoscale

topographies, where the fluid fills the voids and spaces defined by the roughened surface and covers the topographical features. The fluid repellency and the self-healing property of SLIPS can be attributed to the ultra-smoothness of the surface of the fluid, which is capable of recovering its original shape upon external deformation. As used herein, "ultra-smooth" surface means a surface having a roughness factor that is equal or close to 1 , where the roughness factor (R) is defined by the ratio of the real surface area to the projected surface area. Because fluid surfaces generally have a roughness factor of 1 , and the top surface in SLIPS is a lubricating fluid that fully coats the substrate above its hills, surfaces such as that shown in FIG. 1 can be called ultra-smooth. In certain embodiments, ultra-smooth surface can have an average surface roughness is on the order of or less than about 1 nm. In certain embodiments, "ultra-smooth" may refer to a substantially molecularly or even atomically flat surface. The absence of any defects or roughness on such a surface may aid in minimizing the pinning points for a sliding fluid, thus reducing the contact angle hysteresis, rendering it nearly friction- free and slippery. A detailed discussion of the ultra- smooth surfaces is found in co-pending U.S. Patent Application No. 61/434,217, filed on January 19, 2011, U.S. Patent Application No. 61/466,352, filed on March 22, 2011, and co-filed PCT Application No. entitled "Slippery Surfaces With High Pressure

Stability, Optical Transparency, and Self-Healing Characteristics" filed January 19, 2012, which are incorporated by reference in their entirety.

[0111] A schematic of the overall design of SLIPS is illustrated in FIG. 1. As shown, the article includes a surface 100 having raised features 110 that provide a certain roughness with lubricating fluid applied thereon. Lubricating fluid 130 wets the roughened surface, filling the hills and valleys of the roughened surface 110, and forming an ultra- smooth surface 135 over the roughened surface. The top (i) and bottom (ii) scanning electron microscope (SEM) images in the inset of FIG. 1 ultra-smoothness of the SLIPS surface and the porous structure of the underlying rough solid surface, respectively. The surface smoothing effect of the SLIPS device is further illustrated in FIG. 6A and FIG. 6B). FIG. 6 (A) shows a scanning electron microscope image of the surface morphologies of a 3D porous solid. FIG. 6(B) shows a photograph at the same magnification of a slippery surface formed by infiltrating the 3D porous solid shown in FIG. 6(A) with lubricating fluid. The lubricating fluid overcoats the surface topographies of the porous solid to form an ultra-smooth layer without asperity (e.g., average roughness on the order of or less than about 1 nm based on high resolution atomic force microscopy measurements). In certain embodiments, the average surface roughness of SLIPS is on the order of or less than about 1 nm based on high resolution atomic force microscopy measurements. The presence of the micro/nanostructures can significantly enhance the wetting of lubricating fluid, thereby creating a uniformly-coated slippery functional layer over the topographies. [0112] Any arbitrary liquid (e.g., a biological fluid), gas, molecule, or particulate contained within liquids may be strongly repelled from the ultra-smooth lubricating fluid surface. Moreover, the ultra-low adhesion characteristics of SLIPS, which also prevents adsorption, adhesion, and attachment of objects on SLIPS, prevents contamination of these surfaces by material of biological origin. The adhesion, adsorption, or attachment of biological materials can be completely prevented by SLIPS. In some embodiments, SLIPS reduces the adhesion, adsorption, or attachment of biological materials on surfaces. In one aspect, SLIPS significantly reduces adhesion, adsorption, or attachment of biological materials on surfaces. In one or more aspects, SLIPS reduces adhesion, adsorption, or attachment of materials of biological origin on surfaces by 50%, 60%, 70%>, 80%>, 90%>, 95%, 98%, or 99%.

[0113] A wide range of materials can be repelled by the slippery surfaces of the present disclosure. More specifically, polar and non-polar liquids, as well as polar and non-polar liquids in their solidified forms can be repelled by SLIPS. For example, hydrocarbons and their mixtures (e.g., from pentane up to hexadecane and mineral oil, ketones (e.g., acetone, etc.), alcohols (e.g., methanol, ethanol, isopropanol, dipropylene glycol, ethylene glycol, and glycerol, etc.), water (with a broad range of salinity, e.g., sodium chloride from 0 to 6.1 M; potassium chloride from 0 to 4.6 M, etc.), physiological buffers, acids (e.g.,

concentrated hydrofluoric acid, hydrochloric acid, nitric acid, etc), bases (e.g., potassium hydroxide, sodium hydroxide, etc), ice, and the like can be repelled by SLIPS. Moreover, biological objects, such as small animals, protozoa, bacteria, viruses, and the like can be repelled by surfaces made in accordance with the present disclosure. Similarly, solid particles suspended in liquid can be repelled by SLIPS. Non- limiting examples of such solid particles in liquid include bodily fluids, fecal matter, and the like.

[0114] The list is intended to be exemplary and the slippery surfaces of the present disclosure are envisioned to successfully repel numerous other types of biological materials.

Substrates

[0115] In one embodiment, the substrate is a low- surface energy porous solid. In the disclosed embodiments, the substrate is preferentially wetted by the lubricating fluid rather than by the fluid to be repelled. It can have a roughened or smooth surface. As used herein, the term "roughened surface" is a substrate that includes both the surface of a three- dimensionally porous material as well as solid surface having certain topographies, whether they have regular, quasi-regular, or random patterns. In some embodiments, the substrate is roughened by incorporation of microtextures. In other embodiments, the substrate is roughened by incorporation of nanotextures. Physically, the large surface area provided by micro/nanoscale roughness not only facilitates complete wetting by the lubricating fluid but also strengthens the adhesion of lubricating fluid (Liquid B) within the porous solid.

[0116] SLIPS have properties that are insensitive to the precise geometry of the underlying substrate. Therefore, the geometry of the substrate can be any shape, form, or configuration to suit various-shaped materials and devices. In certain embodiments, the porous surface can be manufactured over any suitable materials and geometries, such as medical devices, inside of pipes (e.g., metallic or metallized pipes), optical windows, biological sensor windows, medical tubing, hollow metallic structures, patterned electrodes, meshes, wires, porous conductive surfaces, and the like that come into contact with biological materials. Some exemplary shapes over which the porous surface can be formed are shown in FIGS. 7A-E. Non- limiting examples of shapes, forms, and configurations SLIPS can take include generally spherical (e.g., bead, magnetic particles, and the like), tubular (e.g., for a cannula, connector, catheter, needle, capillary tube, tubing, or syringe) (see FIG. 7A j)), planar (e.g., for application to a microscope slide, plate, film, or laboratory work surface) (see FIG. 7A(c)), or arbitrarily shaped (e.g., well, well plate, Petri dish, tile, jar, flask, beaker, vial, test tube, column, container, cuvette, bottle, drum, vat, or tank) (see FIG. 7A(a)-(b), (d)-(i)). For example, SLIPS can be applied to spherical surfaces, such as magnetic particles that can be actuated inside the body for drug delivery. FIG. 7B-E are perspective illustrations that show how SLIPS can be incorporated into a catheter tube. For example, FIG. 7B shows a SLIPS 700 attached to the outer surface of a cylindrical solid core 710 with a reservoir 720 for Liquid B. Alternatively, SLIPS can also be attached to the inner surfaces of the tubes, pipes, and other irregularly shaped substrates. For example, as shown in FIG. 7C, SLIPS 700 can be can be applied to the inner surface of a cylindrical tube 710 for low drag flow of Liquid A 730. In addition, as shown in FIG. 7D, SLIPS can be applied onto both the inner and outer surfaces of a tube/needle for low drag flow of Liquid A and remain slippery/non-sticking to the outside environments where the tube/needle is exposed to. Also, as shown in FIG. 7E, SLIPS can be applied onto a Liquid-B-soaked porous tubing for low drag flow of Liquid A and remain slippery/non- sticking to the outside environments where the porous tube/needle is exposed to.

[0117] FIG. 5A to FIG. 5D show some exemplary roughened surfaces. In one embodiment, the roughened surface is formed over a two-dimensionally flat surface 500 by providing certain raised structures 510 or protrusions (see FIG. 5A). In another embodiment, the roughened surface is formed by forming pores 520 over a two- dimensionally flat surface 500 to yield a porous material (see FIG. 5B). Pores can take any geometry and can have pathways, columns (as illustrated in FIG. 5B or more random pathways. In yet another embodiment, a three-dimensionally interconnected network of regular or random pores is used (see FIG. 5C and FIG. 5D). FIG. 10 shows images of substrate structures and topologies that can be used to generate SLIPS surfaces; (A) open- cell bricks, (B) post arrays, (C) parallel grooves, (D) open porosity PTFE (ePTFE), (E) plasma-etched PTFE, and (F) sand-blasted polypropylene (PP).

[0118] A range of surface structures with different feature sizes and porosities can be used. Feature sizes can be in the range of hundreds of nanometers to microns (e.g., 100 to 1000 nm), and have aspect ratios from about 1 : 1 to 10: 1. Porous nano-fibrous structures can be generated in situ on the inner surfaces of metallic microfluidic devices using electrochemical deposition using techniques known in the art (Aizenberg, J., Kim, P.

Hierarchical Structured Surfaces Resistant to Wetting by Liquids. United States

Provisional Patent, Application No.: 61/353,505, filed on 7/19/2010; Kim, P., Epstein, A.K., Khan, M., Zarzar, L.D., Lipomi, D.J., Whitesides, G.M., Aizenberg, J. Structural Transformation by Electrodeposition on Patterned Substrates (STEPS): A New Versatile Nanofabrication Method", Nano Letters, in press (2011)).

[0119] In certain embodiments, the surface has a large surface area that is readily wetted by the lubricating fluid and which entrains lubricating fluid and retains it on the substrate surface. In certain embodiments, the substrate surface is a hierarchical surface containing surface features on multiple dimension scales. By way of example, the surface can have a first topological feature having dimensions on the microscale and a second topological feature on the nanoscale. The first topological feature supports the second smaller topological feature. The second topological features are referred to as "primary structures" as they are meant to denote the smallest feature sizes of the hierarchical structure. The primary structures can include structures, such as nanofibers, nanodots, and the like. Such nanoscale "primary structures" can have at least one kind of feature sizes that are a few to tens or hundreds of nanometers in size, such as less than 5 nm to 200 nm. For example, nanofibers having diameters of approximate 5, 10, 25, 50, or even 100 nm. In such cases, when "primary structures" having feature sizes of about 100 nm diameter is utilized, "secondary structures" having feature sizes that are larger than 100 nm, such as 150 nm, 300 nm, 500 nm, or 1000 nm, and larger. Additional higher order structures, such as "tertiary structures" and the like, which each has larger feature sizes than the lower order structures are contemplated.

[0120] Particularly, hierarchical structures having nanofibers as the primary structures may provide a high degree of three-dimensional porosity that may be well-suited for use as porous surfaces described herein. A detailed discussion of hierarchical surfaces suitable for use with a liquid to be repelled is found in International Application No. PCT/US11/44553 entitled "Hierarchically structures surfaces to control wetting by liquids," filed on July 19, 2011, which is incorporated in their entirety by reference.

[0121] In certain embodiments, the roughened surface may have a periodic array of surface protrusions (e.g., posts, peaks, etc.) or any random patterns or roughness (see, e.g., FIG. 5A). In some embodiments, the size of the features producing a roughened surface range from 10 nm to 100 μιη with geometries ranging from regular posts/open-grid structures to randomly oriented spiky structures. In some embodiments, the widths of the raised structures are constant along their heights. In some embodiments, the widths of the raised structures increase as they approach the basal surface from the distal ends. The raised structures can be raised posts of a variety of cross-sections, including, but not limited to, circles, ellipses, or polygons (such as triangles, squares, pentagons, hexagons, octagons, and the like), forming cylindrical, pyramidal, conical or prismatic columns. Although the exemplary substrates described above illustrate raised posts having uniform shape and size, the shape, orientation and/or size of raised posts on a given substrate can vary.

[0122] Open porosity PTFE (ePTFE) membranes can be pressed or molded to take on a variety of shapes, as is illustrated in FIGS. 35A-C and FIG. 33). FIG. 35 shows images of a process for fabricating a SLIPS tubing from ePTFE membranes in which (A) A tubular structure (center) is formed from two flat ePTFE membranes (1.0 μιη pore size) by being pressed between two U-shaped channel molds (left and right). (B) One ePTFE membrane is pressed between the negative and positive molds, producing an indented channel structure for fluidic flow. This structure was then covered and bound to a flat ePTFE membrane to construct the SLIPS U-shape tube shown in (A). Low (left) and high (right) magnification views of scanning electron microscope (SEM) images (C) of a cross-section of the pressed ePTFE membrane; porous fibrous structure is visible at the right. FIG. 33 shows images of ePTFE tubing (Zeus Inc) of increasing inner diameter (ID), from 0.075" to 0.236" (wall thickness is -0.040" for all) (A). The commercially available tubing is made by expanding PTFE tubing during the manufacturing process to create microscopic pores in the structure of the material. The 0.180" ePTFE tubing (which provides a porous microtexture to the substrate) can be fit with an elastic, external, silicone tube casing (VWR), for example, to provide a fluid flow barrier and/or to facilitate peristaltic pumping. High magnification SEM of the porous ePTFE surface within the tubing is also shown (B).

[0123] In certain embodiments, the roughened surface has a roughness factor, R, greater than 1 , where the roughness factor is defined as the ratio between the real surface area and the projected surface area. For complete wetting of lubricating fluid to occur, it is desirable to have the roughness factor of the roughened surface to be greater or equal to that defined by the Wenzel relationship (i.e., R≥ l/cos( , where Θ is the contact angle of lubricating fluid on a flat solid surface). For example, if lubricating fluid has a contact angle of 50° on a flat surface of a specific material, it is desirable for the corresponding roughened surface to have a roughness factor greater than ~1.5.

[0124] The roughened surface material can be selected to be chemically inert to the lubricating fluid and to have good wetting properties with respect to lubricating fluid. In addition, the roughened surface topographies can be varied over a range of geometries and size scale to provide the desired interaction, e.g., wettability, with lubricating fluid.

[0125] In certain embodiments, the micro/nanoscale topographies beneath the lubricating fluid enhance the liquid- wicking property and the adherence of lubricating fluid to the roughened surface. As a result, the lubricating fluid can uniformly coat the roughened surface and get entrapped inside at any tilting angles.

[0126] Non-limiting examples of porous materials include solid substrates having holes (e.g., high aspect ratio holes, cylinders, columns, etc.), three-dimensionally interconnected network of holes and one or more materials (e.g., 3-D ordered colloidal assemblies, block copolymers, etc.), and random array of fibrous materials (e.g., filter paper, fabrics, electrospun films). [0127] Non-limiting examples of porous or rough surface structures that can be used include polymers (e.g., polysulfone, PDMS, and polypyrrole) and hydrophobic porous (e.g., Tefion) materials. For example, the roughened surface can be manufactured from polymers (e.g., epoxy, polycarbonate, polyester, nylon, etc.), metals, sapphire, glass, carbon in different forms (such as diamond, graphite, black carbon, etc.), ceramics (e.g., alumina), and the like. For example, fluoropolymers such as polytetrafluoroethylene (PTFE), polyvinylfluoride, polyvinylidene fluoride, fluorinated ethylene propylene, and the like can be used as substrates. Many porous materials are commercially available, or can be made by a number of well-established manufacturing techniques. For example,

polytetrafluoroethylene (also known by the trade name "Teflon" and abbreviation "PTFE") filter materials are commercially available. In some embodiments, the roughened surface is manufactured from a hemocompatible material, non-limiting examples of which include silicon rubber and polysulfones. In certain embodiments, the roughened surface is manufactured from any suitable materials. In certain embodiments, if the desired material and shape is not electrically conducting, the surfaces of such material and shapes can be rendered electrically conductive by applying a thin layer of conductive material, such as through vapor deposition techniques, sputtering, metallization techniques, and the like. Moreover, the porous surface can be readily formed on large surface area materials that are commercially important. When necessary, surface functionalization can be carried out to modify the solid surfaces so that the lubricating layer preferentially wets the roughened surface as compared to Liquid A.

[0128] The raised structures can be produced by any known method for fabricating raised structures onto substrates. Non- limiting examples include molding into the device structure, conventional photolithography, projection lithography, e-beam writing or lithography, depositing nanowire arrays, growing nanostructures on the surface of a substrate, soft lithography, replica molding, solution deposition, solution polymerization, electropolymerization, electrospinning, electroplating, vapor deposition, contact printing, etching, bead blasting, sand blasting, transfer patterning, microimprinting, self-assembly, and the like.

[0129] In certain embodiments, the roughened surface can be made, for example, by replica molding procedure described in B. Pokroy, A. K. Epstein, M. C. M. Persson-Gulda, J. Aizenberg, Adv. Mater. 21, 463 (2009), the contents of which is incorporated by reference herein in its entirety. Patterned surfaces can also be obtained as replicas (e.g., epoxy replicas) by a soft lithographic method (see, e.g., J. Aizenberg and B. Pokroy, PCT/US2009/048880, the contents of which is incorporated by reference herein in its entirety). Polymer films with patterned surfaces can be fabricated by means known in the art (e.g., roll-to-roll imprinting or embossing). By way of non-limiting example, negative replicas of pre-generated patterns can be made from polydimethylsiloxane, PDMS (e.g., Dow-Sylgard 184) by pouring mixture of prepolymer and curing agent (e.g., 10: 1 ratio) on the patterns followed by thermal curing in an oven. After cooling, the negative PDMS mold can be peeled off and used for fabricating the final replica by pouring the desired material (e.g. UV-curable epoxy resin) into the negative mold. After solidifying the material, the negative mold can be peeled off, leaving the replica of the original pattern. Then, the surface of the replica can be chemically functionalized with low surface energy coating such as (tridecafluoro-l,l,2,2-tetrahydrooctyl)-trichlorosilane.

[0130] For example, a silicon substrate having a post array such as is illustrated in FIG. 5A can be fabricated by photolithography using the Bosch reactive ion etching method (as described in Plasma Etching: Fundamentals and Applications, M. Sugawara, et al., Oxford University Press, (1998), ISBN-10: 019856287X, the contents of which is incorporated by reference herein in its entirety).

[0131] Arrays of hydrophobic raised surface structures can be made at the micrometer scale using micromolding techniques. For example, rough surface structures can be arrays of hydrophobic raised surface structures at the micrometer scale, such as posts and intersecting walls patterned in polymers such as epoxy (FIG. lOA-C).

[0132] In certain embodiments, the roughened surface may be the surface of a three- dimensionally porous material (see, e.g., FIG. 5B to FIG. 5D). The porous material can be any suitable porous network having a sufficient thickness to stabilize lubricating fluid, such as a thickness from about 5 μιη to about 1 mm. Moreover, the porous material can have any suitable pore sizes to stabilize the lubricating fluid, such as from about 10 nm to about 100 μιη.

[0133] In another embodiment, porous alumina is manufactured by the process of anodization as shown in FIG. 5B, where an aluminum substrate is electrochemically oxidized under constant electrical potential. The pore size, inter-pore spacing, and aspect ratio of the pores can be tuned by adjusting the operating parameters of the electrochemical oxidation process. Such a process generates porous through-holes into the substrate, where the size of the porous holes are on the order of 50 nm with aspect ratio larger than 10000 (see, Lee et al, Nature Mater. 5, 741-47, 2006, the contents of which is incorporated by reference herein in its entirety.).

[0134] In some embodiments, mechanical or (electro)chemical methods can be used to roughen metal surfaces. Roughening and non- wetting materials can be spray coated directly onto metal surfaces. Boehmite (γ-ΑΙΟ(ΟΗ)) formation on aluminum surface by boiling in water can also be used to roughen metallic surfaces such as aluminum. Rotary jet spinning of hydrophobic polymer nano fibers and layered deposition of an appropriate primer can also be used to roughen substrates for use in SLIPS.

[0135] In yet another embodiment, long range ordered porous structures of silica, as shown in FIG. 5C, can be produced by evaporative co-assembly method of sacrificial polymeric colloidal particles together with a hydrolyzed silicate sol-gel precursor solution. Such a method generates a crack-free porous surface on the order of centimeters or larger, with pore sizes of about 100 nm to about 1000 nm and porosity of about 75%. (See, Hatton, et al, Proc. Natl. Acad. Sci. 107, 10354-10359, 2010 and U.S. Patent Application No. 13/058,611, filed on February 11, 2011, the contents of which is incorporated by reference herein in its entirety.).

[0136] Referring to FIG. 5D, polymer-based porous membrane (such as medical grade PTFE) can be made by mixing PTFE powders with lubricating fluid to form a paste. Then, the paste can be molded into the desired shape by methods such an extrusion molding. The molded PTFE membrane can then be heated up to less than its melting point to drive off the lubricants. Thereafter, a porous PTFE membrane can be formed (see U.S. Patent No.

5,476,589, the content of which is incorporated by reference herein in its entirety).

[0137] In yet another embodiment, the porous material can be generated in-situ on a metal surface by an electrodeposition method, such as the STEP method (STEP = structural transformation by electrodeposition on patterned substrates, see, PCT Application No. PCT/US11/44553, filed on July 19, 2011, and Kim, et al, Nano Lett., in press, (2011), the contents of which are incorporated by reference herein in their entirety. The

electrodeposition condition can be controlled so that nanofibers of electrically conductive polymer can be formed over an electrically conductive surface. The electrodeposition conditions can further be controlled to provide a desired nanofiber diameter and spacing. In certain embodiments, the electrodeposition condition can be controlled to provide any other desirable morphology that can provide additional means to stabilize the lubricating layer.

[0138] The morphology of the conducting organic polymers can be controlled by varying the deposition conditions such as the concentration of monomer, the types of electrolytes and buffers, the deposition temperature and time, and the electrochemical conditions such as applied potential. For example, increasing the concentration of monomer in the electrochemical solution, the applied potential, and/or the temperature generally leads to a faster polymerization rate and many parasitic nucleation sites during growth resulting in a morphology that is similar to a cauliflower (see FIG. 24A). In contrast, lower concentrations of monomer, lower applied potential, and lower temperatures can lead to nanofibrile growth with substantially uniform diameters (see FIG. 24B).

Further decrease in concentration of monomer or applied potential can lead to short rods of polymer nano fibers with low surface coverage (see FIG. 24C). In another example, increasing the type of electrolytes and buffers to obtain a more acidic solution can lead to the formation of a cauliflower shape (see FIG. 24A) or overgrowth of polymers (see

FIG. 24D). In another example, the applied voltage can be cycled leading to different oxidation states of the deposited polymer layer which is often manifested as a color change (e.g., from dark blue to a green then to a pale yellow color with increasing applied voltage). In yet another example, the applied voltage can be pulsed at a constant voltage to form polymers only on the tip of the underlying micropost structures, leading to a mushroom-like morphology (see FIG. 24E). Accordingly, the morphology of conducting organic polymers can be finely controlled from nanometers to over micrometer scales, and surface coatings with precisely controlled morphology can be produced by simple modifications, which promise the customization of various surface properties by design and control of the morphology.

[0139] In other embodiments, a roughened surface is further functionalized to improve wetting by lubricating fluid. Surface coating can be achieved by methods well known in the art, including plasma assisted chemical vapor deposition, chemical functionalization, solution deposition, and vapor deposition. For example, surfaces containing hydroxyl groups (i.e., -OH) can be functionalized with various commercially available fluorosilanes (e.g. , tridecafluoro- 1 , 1 ,2,2-tetrahydrooctyl-trichlorosilane, heptadecafluoro- 1 , 1 ,2,2-tetra- hydrodecyl trichlorosilane, etc.) to improve wetting by low surface tension fluids. In certain embodiments, many materials having native oxides, such as silicon, glass, and alumina, can be activated to contain -OH functional groups using techniques such as plasma treatment. After activation, either vapor or solution deposition techniques can be used to attach silanes so that surfaces with low surface energy can be produced. For vapor deposition, the deposition can be carried out by exposing the surface to silane vapors. For solution deposition, the deposition can be carried out by immersing the surface in a silane solution, followed by rinsing and blow-drying after deposition. For layered deposition, layered deposition of a primer is followed by application of a mixture of sacrificial beads and Liquid B, which is dried and cured. The beads are removed to produce a contiguous porous Teflon- like surface.

[0140] In some other embodiments, where hydroxyl groups is absent on the surface, the surface can be functionalized by first coating it with thin films of metals, such as gold or platinum, and the thin metal films can be functionalized with various commercially available thiols of low surface energy (e.g., heptane thiol, perfluorodecanethiol, etc.).

Similarly, vapor or solution deposition techniques can be carried out similar to that describe for silane deposition using, for example, alkane thiol solutions.

[0141] In another embodiment, the roughened, porous substrate can be generated by a spraying method, where emulsions consisting of micro/nanoparticles are sprayed onto a flat solid surface (FIG. 14A1). These particles assemble into roughened solid layer upon solvent drying. Such a solid layer can then be infiltrated by lubricating fluid (FIG. 14A2) (which can also be applied by additional spraying). FIG. 14A shows a surface roughened by a spray method. Here, the substrate 140 is roughened by spraying or depositing a particulate matter 142 on the substrate 140 to create a porous coating (Al) and the roughened surface is infiltrated with lubricating liquid 144. Non-limiting examples of micro/ nanoparticles that can be sprayed onto a flat solid surface to form roughened, porous material include titanium dioxide, silicon dioxide, nanodiamonds, metals such as silver, gold, platinum, copper, gold, palladium, zinc, and titanium, hydroxyapatite (HAp) nanoparticles.

[0142] In one or more embodiments, the roughened, porous substrate is generated by chemical or physical etching, which includes mechanical roughening such as bead blasting and sand blasting. Referring to FIG. 14B, the substrate 140 is roughened by etching (Bl). The etchant 148 is carried by a preformed pipe 146 and deposited onto the substrate 140 to create a roughened surface. Once the surface is roughened, it is functionalized (B2) with a liquid (not shown) or vapor silane 150, and infiltrated with a lubricating liquid 144 (B3).

[0143] In other embodiments, the roughened, porous substrate is made by growing a nanostructured material on the surface. In FIG. 14C, a nanostructured material 152 is grown on the surface of the substrate 140 to create a roughened surface (CI) that is functionalized (C2)) with a liquid (not shown) or vapor silane 150 and infused with a lubricating liquid 144 (C3). Non-limiting examples of these nanostructures include PPy nanofibers, carbon nanotubes, and the like. One the nanostructures are in place, the surface can be chemically functionalized by silanization (FIG. 14C2) and infiltrated with a lubricating liquid (FIG. 14C3).

[0144] In certain embodiments, the roughened surface can be formed over or applied to a variety of planar or non-planar surface (see FIG. 7 and FIG. 8A-B). For example, FIG. 8B shows a porous membrane attached to the outer surface of a cylindrical solid core. It can also be attached to the inner surfaces, outer surfaces, or inner and outer surfaces of tubes and other irregularly shaped substrates.

[0145] In certain embodiments, the solid surface may be substantially flat. This situation may be applicable when the critical surface energy of the flat surface is higher than the surface tension of the functional lubricating fluid.

[0146] In certain embodiments, the roughened surface can have pores that are comparable or smaller than the material to be repelled. For example, pore sizes that are smaller than the size of protozoa (e.g., 10 μιη), bacteria (e.g., 1 μιη), viruses (e.g., 0.1 μιη), and the like can be utilized.

[0147] In one or more of the above embodiments, non-limiting examples of surface to which SLIPS is applied include a cannula, connector, catheter (e.g., central line, peripherally inserted central catheter (PICC) line, urinary, vascular, peritoneal dialysis, and central venous catheters), catheter connector (e.g., Leur-Lok and needleless connectors), clamp, skin hook, cuff, retractor, shunt, needle, capillary tube, endotracheal tube, ventilator, associated ventilator tubing, drug delivery vehicle, syringe, microscope slide, plate, film, laboratory work surface, well, well plate, Petri dish, tile, jar, flask, beaker, vial, test tube, tubing connector, column, container, cuvette, bottle, drum, vat, tank, organ, organ implant, or organ component (e.g., intrauterine device, defibrillator, corneal, breast, knee replacement, and hip replacement implants), artificial organ or a component thereof (e.g., heart valve, ventricular assist devices, total artificial hearts, cochlear implant, visual prosthetic, and components thereof), dental tool, dental implant (e.g., root form, plate form, and subperiosteal implants), biosensor (e.g., glucose and insulin monitor, blood oxygen sensor, hemoglobin sensor, biological microelectromechanical devices (bioMEMs), sepsis diagnostic sensor, and other protein and enzyme sensors), bioelectrode, endoscope

(hysteroscope, cystoscope, amnioscope, laparoscope, gastroscope, mediastinoscope, bronchoscope, esophagoseope, rhinoscope, arthroscope, proctoscope, eoloiioscope, nephroscope, atigioscope, thoracoscope, esophagoseope, laryngoscope, and

encephaloscope) wound dressing (e.g., bandages, sutures, staples), and combinations thereof.

Lubricating Fluids (Liquid B)

[0148] Lubricating fluids are selected to create a fluid surface that is intrinsically smooth, stable, and defect free. The lubricating fluid should infiltrate, wet, and stably adhere to the substrate. Moreover, it should be chemically inert with respect to the solid substrate and the fluid to be repelled. In certain embodiments, a lubricating fluid possesses the ability to form a substantially molecularly flat surface when provided over a roughened surface. In certain other embodiments, a lubricating fluid possesses the ability to form a substantially atomically flat surface when provided over a roughened surface. In one or more embodiments, the lubricant is substantially incompressible.

[0149] Further, the lubricating fluid is capable of repelling immiscible fluids, and in particular biological fluids of any surface tension. For example, the enthalpy of mixing between the fluid to be repelled and lubricating fluids be may be sufficiently high (e.g., water and oil) that they phase separate from each other when mixed together. In certain embodiments, the lubricating fluid can be selected such that the fluid to be repelled has a small or substantially no contact angle hysteresis. For example, contact angle hysteresis less than about 5°, 2.5°, 2°, or even less than 1° can be obtained. Low contact angle hysteresis encourages sliding at low tilt angles (e.g., < 5°), further enhancing fluid repellant properties of the surface.

[0150] The effectiveness of a given lubricating fluid's ability to repel fluids can be confirmed by visualization techniques known in the art including fluorescence microscopy and scanning electron microscopy (SEM). [0151] In one or more embodiments, lubricating fluid is inert with respect to the solid surface and biological fluid. Lubricating fluid flows readily into the recesses of the roughened surface and generally possesses the ability to form an ultra-smooth surface when provided over the roughened surface. FIG. 4A shows a droplet 400 of perfluoro- tripentylamine (herein referred to by the trade name "FC-70") lubricating fluid on an unstructured surface 410 of a flat surface prepared from a slanted epoxy resin. The dashed line represents the location of the upper surface of the substrate. The droplet spreads out on the flat surface, but retains a droplet form. FIG. 4B shows the same lubricating fluid on an exemplary roughened surface of the same composition 420 having nanostructures, the features of which are shown in the inset. As shown, the nanostructures greatly enhance the wetting of the lubricating fluid on the surface, creating a uniformly-coated slippery functional layer over the topographies. The resulting ultra-smooth surface is capable of repelling fluids including, but not limited to biological fluids and particles in solution or suspension.

[0152] Lubricating fluid can be selected from a number of different fluids. These fluids can be selected based on their biocompatibility, low (or high) toxicity, anti-clotting performance, chemical stability under physiological conditions, and levels of leaching from the surfaces of the devices. For example, compounds that are approved for use in biomedical applications (e.g., blood substitutes, MRI contrast agents), such as

perfluorinated hydrocarbons and organosilicone compounds (e.g. silicone elastomer) can be used as lubricating fluids. In one or more aspects, the lubricating fluid is a chemically- inert, high-density biocompatible fluid, non-limiting examples of which include tertiary perfluoroalkylamines (such as perfluorotri-n-pentylamine, FC-70, perfluorotri-n- butylamine FC-40, etc ), perfluoroalkylsulfides and perfluoroalkylsulfoxides,

perfluoroalkylethers, perfluorocycloethers (like FC-77) and perfluoropolyethers (such as K YTOX family of lubricants by DuPont), perfluoroalkylphosphines and

perfluoroalkylphosphineoxides, and combinations thereof are used. . In addition, long- chain perfluorinated carboxylic acids (e.g., perfluorooctadecanoic acid and other homologues), fluorinated phosphonic acids, fluorinated silanes, and combinations thereof can be used as Liquid B. Perfluoroalkyls can be linear or branched.

[0153] In certain embodiments, the lubricating fluid has a high density. For example, the lubricating fluid has a density that is more than 1.0 g/cm³, 1.6 g/cm³, or even 1.9 g/cm³. In certain embodiments, the density of the lubricating fluid is greater than that of the biological fluid to enhance fluid repellency. High density fluids reduce the tendency of an impacting fluid to 'sink' below the surface of lubricating fluid and to become entrained therein. In certain embodiments, the density of Liquid A may be lower than that of the lubricating liquid. For example, density of Liquid A may be at least ~1.5 times lower than that of the lubricating liquid.

[0154] In certain embodiments, the lubricating fluid has a low evaporation rate, such as less than 100 nm/s, less than 10 nm/s, or even less than 1-2 nm/s. The lubricating fluid should be applied in a thickness sufficient to cover the rough surface of the substrate and provide an ultra-smooth surface. Taking a typical thickness of the lubricating fluid to be about 10 μιη and an evaporation rate of about 1-2 nm/s, SLIPS can remain highly fluid- repellant for a long period of time without any refilling mechanisms.

[0155] In certain embodiments, lubricating fluid has a low freezing temperature, such as less than -5°C, -25°C, or even less than -50°C. Having a low freezing temperature allows lubricating fluid to maintain its slippery behavior to repel a variety of liquids or solidified fluids, such as ice and the like and over a range of temperatures.

[0156] Experimentally, it is observed that Object A can become highly mobile on the surface of the lubricating liquid when the kinematic viscosity of the lubricating liquid is less than 1 cm²/s. Since liquid viscosity is a function of temperature (i.e., liquid viscosity reduces with increasing temperature), choosing the appropriate lubricant that operates at the aforementioned viscosity (i.e., < 1 cm²/s) at specific temperature range is desirable.

Particularly, various different commercially available lubricating liquid can be found at the specified viscosity, such as perfluorinated oils (e.g., 3M™ Fluorinert™ and DuPont™

Krytox® oils), at temperatures ranging from less than - 80 °C to greater than 260 °C. For example, the temperature dependence of liquid viscosity of DuPont Krytox oils is shown in the Table 1 as a specific example (note: data is provided by the manufacturer of DuPont Krytox oils).

Table 1. Temperature dependence of liquid viscosity of DuPont Krytox Oils.

Viscosity (cm²/s)

Temperature Krytox Krytox Krytox Krytox Krytox Krytox Krytox Krytox

100 101 102 103 104 105 106 107

20 0.124 0.174 0.38 0.82 1.77 5.22 8.22 15.35 40 0.055 0.078 0.15 0.30 0.60 1.60 2.43 4.50 100 0.02 0.03 0.05 0.084 0.18 0.25 0.42

204 0.031 0.041 0.06

260 0.024 0.033

[0157] The viscosities of both Object A and Liquid B affect the performance of SLIPS. Because the liquid repellency of SLIPS is conferred by the presence of the Liquid B, the viscosity of Liquid B can affect the physical characteristics of liquid repellency of SLIPS, such as the velocity of Object A. The more viscous the Liquid B, the less mobile the given Liquid A will be.

[0158] For a Liquid A of constant viscosity, its velocity on SLIPS reduces with increasing viscosity of Liquid B. For example, referring to FIG. 36, for a 50 of Liquid A of absolute viscosity of 1 cP, its velocities on SLIPS with Liquid B of viscosities of 13 cP, 140 cP, and 990 cP are -17 cm/s, -5.8 cm/s, and -0.98 cm/s, respectively. Therefore, to enhance the velocity of Liquid A on SLIPS, it is desirable to use a Liquid B having a lower viscosity. This general trend is consistent for Liquid A of viscosities ranging from 1 cP to 1000 cP.

[0159] Lubricating fluid can be deposited in any desired thickness, provided the top surface of lubricating fluid forms an ultra-smooth surface and is retained and interacts with the underlying surface. If the liquid layer is too thick, the upper surface is 'unbound' from the underlying surface and will flow with Liquid A from the SLIPS surface. The liquid layer that interacts with and is retained by the underlying surface is referred to as the

'characteristic thickness' of the liquid layer. The characteristic thickness will vary

depending on the underlying surface and the ambient conditions, e.g., temperature, pressure, etc. Film thicknesses substantially on the order of the surface roughness peak-to- valley distance provide good fluid-solid interaction between the substrate and lubricating fluid. When the solid substrate is tilted at a position normal to the horizontal plane, lubricating fluids with thicknesses below a characteristic length scale remain substantially adhered to the roughened surface, whereas fluid layers above the characteristic length can flow, creating flow lines (surface defects) and disrupting the flatness of the fluid surface. For example, non-limiting thicknesses for the lubrication fluid (as measured from the valleys of the roughened surface are on the order of 5-20 μιη when the peak to valley height is -5 um. [0160] In certain embodiments, lubricating fluid can be applied by pupating drops of the fluid onto the roughened surface, or by dipping the roughened surface into a reservoir carrying lubricating fluid. In some embodiments, lubricating fluid can be sprayed, cast, or drawn onto the roughened surface. The lubricating liquid can infiltrate the roughened surface by capillary action, which can wet the roughened surface and form a film on top of it. Lubricating fluid and the roughened surface can be both generated by a double-spraying process, where emulsions consisting of nano/microparticles are first sprayed onto a flat solid surface to form a substantially roughened solid layer, and then lubricating fluid can be sprayed onto this freshly formed layer for further infiltration. In addition, lubricating fluid may infiltrate into the pores of the roughened surface by capillary action and form an ultra- smooth film on top of the roughened surface. In certain embodiments, when sufficient quantity of the lubricating fluid is provided, the lubricating fluid may wet the entire roughened surface structure and form an ultra-smooth film over the underlying roughened surface.

Facile Replenishment of Liquid B

[0161] Another advantageous feature of using porous materials may be the presence of the capillary network within the bulk materials, which can further enhance transport of Liquid B through the pores. The porous structure can provide a replenishing fluid at the surface and may be useful to address evaporation or other materials loss of Liquid B from the SLIPS surface. For example, in the case where a portion of Liquid B is reduced at the surface of the materials due to evaporation, sudden pressure purging, physical damage or the like, Liquid B can be replenished by the capillary action in these networks.

Replenishing Liquid B is drawn through the porous body of the substrate by capillary wicking to refresh the upper surface of SLIPS. In certain embodiments, the porous material itself can be utilized as a fluid reservoir to store Liquid B for subsequent capillary refilling purpose.

[0162] In certain embodiments, as shown in FIG. 9A, to further prolong the life time of the slippery surface of the present disclosure, the porous material 905 can be connected to an external fluid reservoir 903 sitting on a solid substrate 901, where the capillary networks within the porous material 905 can help transfer (e.g., via wicking) the Liquid B from the fluid reservoir 903 to the porous material 905. [0163] FIG. 9B shows an alternate embodiment where SLIPS having a porous material 905 as the roughened surface is formed in an inner surface of a cylindrical tube. As shown, the cylindrical tube 901 has a first annular region 903 serving as a fluid reservoir for Liquid B, followed by an inner annular region of SLIPS having a porous material 905, which surrounds a hollow region 907 for the flow of Liquid A. In operation, Liquid B in annular region 903 transfers into the (e.g., via wicking) the porous material 905 to form a SLIPS and Liquid A can flow through the hollow region with little to no drag at the interface between 905 and 907.

[0164] FIG. 9C shows yet another embodiment where SLIPS is formed in an inner surface of an arbitrarily shaped flow path. As shown, the bottom substrate 901 has a channel 903 serving as a fluid replenishment source for Liquid B that is coupled to the porous material 905 of SLIPS. Porous material 905 is formed by combining a bottom substrate 901 having a depressed region mated with a top substrate 909 having a substantially flat porous material 911 formed thereon. The combination of the top and bottom substrate portions forms a hollow region 907 for the flow of Liquid A.

[0165] FIG. 9D shows some optical micrographs on how the bottom substrate 901 and SLIPS 905 of FIG. 9C can be formed. As shown, a TEFLON filter paper 930 having a three-dimensionally random network of pores can be placed between a male mold 940 and female mold 950 defining an arbitrary flow path and the male mold 940 and female mold 950 can be pressed together to replicate the flow path pattern on the TEFLON filter paper 930. The template TEFLON filter paper 930 can be placed inside the female mold 950, which now serves as bottom substrate 901 of FIG. 9C, and a substantially flat substrate 909 having another substantially flat TEFLON filter paper, serving as SLIPS 911, can be applied thereon (not shown) to form the flow path 907 shown in FIG. 9C. The female mold 950 may further contain channel 903 (not shown) that serves to replenish Liquid B as needed.

[0166] FIG. 35 shows several other non-limiting embodiments of SLIPS and how Liquid B can be replenished to the SLIPS in each of those embodiments. The left column corresponds to systems where SLIPS is exposed to both Medium X and Liquid A (shown as a droplet). The right column corresponds to systems where SLIPS is exposed to

substantially only Liquid A (shown as a plug between two SLIPS). In either system, Liquid B can be replenished to SLIPS as needed. The top row shows scenarios where there is a finite amount of Liquid B. The middle row shows scenarios where there is a large source (e.g., practically infinite source from the viewpoint of the amount of Liquid B needed to replenish the SLIPS) of Liquid B. The bottom row shows scenarios where Liquid B can be replenished by spraying Liquid B as needed, either manually or automatically. As shown, many different configurations and their derivatives are possible.

[0167] It should be noted that while the embodiments described herein refers to a porous material, any other suitable roughened surface described herein can be utilized.

Substrate-Lubricating Fluid Combinations

[0168] SLIPS can sustain fluid impact pressures on the order of 10³-10⁷ Pa (e.g., at least from an order of magnitude to five orders of magnitude higher than the current state- of-the-art surface) and are capable of restoring themselves to exceptional liquid repellency upon critical physical damages with a fast self-healing time on the orders of 100 ms to 1 s (i.e., 4 orders of magnitude faster than the current state-of-the-art surface).

[0169] In certain embodiments, the lubricating liquid and the roughened surface can be selected so that they have fast self-healing properties. As used herein, "self-healing" refers to re-formation of an ultra-smooth (and even substantially molecularly flat) surface after physical impact (e.g., damage). The lubricating fluid is a self-healing coating that rapidly restores the fluid-repellant function following damage to the porous material by abrasion or impact. Self healing occurs when the lubricating fluid flows toward the damaged area of the substrate by surface energy-driven capillary action to spontaneously fill the physical void. The recovery time is a function of lubricant viscosity. For example, for Krytox 100, the self-healing time is on the order of 150 ms to 1 s. For Krytox 103, which is more viscous than Krytox 100 the self-healing time is on the order of O(10s) or more. In one or more embodiments, the recovery time for a fluid displacement is less than one second. In other embodiments, the recovery time is a fraction of a second. In still other embodiments, the recovery time is 50 ms, 60 ms, 70 ms, 80 ms, 90 ms, 100 ms, 110 ms, 120 ms, 130 ms, 140 ms, 150 ms, 160 ms, 170 ms, 180 ms, 190 ms, 200 ms, 210 ms, 220 ms, 230 ms, 240 ms, 250 ms, 1 second, 5 seconds 10 seconds, 30 seconds, 60 seconds, 90 seconds, 120 seconds, or more depending on the amount of damage sustained, and the characteristics of the lubricating fluid and substrate used. The self-healing behavior of the liquid repellant surfaces can be a function of the interaction between the lubricating liquid and the roughened surface, as well as the viscosity of the lubricating liquid. Typical kinematic viscosities of the lubricating liquid are in the range of 0.10 cm²/s to 10 cm²/s. Referring to FIGS. 28 and 29, particle impact or scratching can damage the surface by, for example, breaking or removing the topographical features of the surface in a small area. In one embodiment, the measured self-recovery time for a ~50 μιη fluid displacement of FC-70 lubrication fluid on epoxy-resin-based SLIPS was only -150 ms (FIG. 28 A). Typically the impact can also displace the lubricating liquid, resulting in a scratch or pit and exposing the substrate surface. Due to the wicking capability and good wetting properties of the lubricating liquid, however, the liquid layer can flow back to refill the pit or scratch and to regenerate the smooth fluid surface. FIG. 28A shows time-lapse images showing self- healing capability of SLIPS from a ~50 μιη-wide physical damage on a time scale on the order of 100 ms. FIG. 28B is a schematic illustration of the type of damage that may occur and the healing process that restores the smooth liquid surface. A reservoir with extra fluid can be available to 'top off the fluid layer thickness to maintain the desired thickness. Even more surprising, SLIPS can repeatedly restore their fluid-repellent function to surfaces sustaining large areas of physical damage. FIG. 29 is a chart showing restoration of liquid repellency function after critical physical damage (test liquid = decane, YLV = 23.6 ± 0.1 mN/m) in accordance with certain embodiments.

[0170] In certain embodiments, the roughened surface may be functionalized so that the critical surface energy of the roughened surface is higher than the surface energy of lubricating liquid; under these conditions, complete wetting of the lubricating liquid can spontaneously occur throughout the roughened surface.

[0171] In certain embodiments, when the critical surface energy of the roughened surface is lower than the surface energy of the lubricating liquid, the roughened surface may be provided with a high degree of roughness to promote wetting of the lubricating liquid within the pores of the roughened surface.

[0172] In certain embodiments, the lubricating liquid has a surface energy that is less than the surface energy of the roughened surface. In general, when the surface energy of the liquid B is lower than the surface energy of the underlying roughened surface, it tends to wet the solid well. More precisely, the spreading of a liquid depends on the spreading parameter (S), where S=[E_substate]dry-[Es_ubstrate]wet = YSO-(YSL+Y), with y_so , YSL, and γ as the surface energy of at the solid/air, solid/liquid, and liquid/air interfaces, respectively. The liquid wets a surface completely if S>0 while the drop partially wet a surface if S<0. {See, e.g., P.-G. de Gennes, F. Brochard-Wyart, D. Quere, Capillarity and Wetting Phenomena: drops, bubbles, pearls, waves, Springer (New York, NY), 2004, the contents of which is incorporated by reference herein in its entirety). Thus, in certain embodiments, the surface energy of the liquid B is such that the spreading parameter S is positive.

[0173] In certain embodiments, the critical surface tension of the roughened surface (i.e., y_c_s) may be comparable or lower than the surface tension of the lubricating liquid (i.e., 7LV-B)- For example, the critical surface tension of the roughened surface may be at least 1.25 times lower than the surface tension of the lubricating liquid.

[0174] In certain embodiments, the lubricating liquid (and similarly Liquid A) may be non-reactive with the roughened surface. For example, the roughened surface and the lubricating liquid (or liquid to be repelled) can be chosen so that the roughened surface does not dissolve upon contact with the lubricating liquid (or liquid to be repelled). In particular, perfluorinated liquids (the lubricating liquid) work exceptionally well to repel a broad range of polar and non-polar Liquids A and their solidified forms.

[0175] Any suitable combination of the roughened surface and the lubricating liquid described above can be employed. For example, a perfluorinated liquid as the lubricating liquid and a nanostructured surface made out of polymer (for example, epoxy resin, silicone, and Teflon) that are chemically functionalized with end-functional group of -CF₃ or other similar fluorocarbon groups can be utilized as the roughened surface. Other materials including sapphire, diamonds, silicon, glass, and metals (e.g., aluminum) can be also used with suitable chemical functionalization schemes.

[0176] It is contemplated that SLIPS may be incorporated in an environment (1) where the lubricating fluid is exposed substantially only to Object A or (2) where the lubricating fluid is exposed to both Object A and another fluid environment, such as medium X (e.g., atmosphere, underwater, etc.).

[0177] When SLIPS is incorporated in the first environment (e.g., inside the interior of medical tubing, outside the exterior of the medical tubing, and the like) (see FIG. 9B), the working combinations of the solid/lubricant/immiscible test liquid may be chosen by satisfying the condition shown in Equation (el).

AEo = 7BXCOS< BX - 7A COS< AX > 0 (el)

where YAX, and y_Bx represent the surface energies of the Object A-medium X interface, and the lubricating liquid-medium X interface, respectively. Also, ΘΑΧ, and 6½x are the equilibrium contact angles of Object A and the lubricating fluid on a flat solid surface immersed under medium X environment, respectively.

[0178] On the other hand, when SLIPS is incorporated in the second environment (e.g., exposed to atmosphere/underwater/other immiscible fluid environments), satisfying the following two conditions can provide a suitable SLIPS.

AEi = ?0BxCOs6>Bx - 7AXCOS6>AX) - 7AB > 0 (e2)

AE2 =

- 7AXCOS6>AX) + 7AX - 7BX > 0 (e3)

where >Ά_Β represent the surface energies of the Object A-the lubricating fluid interface.

[0179] In addition, when SLIPS is operated in a fully immersed environment (i.e., air/water/other immiscible fluids), the density difference between the Object A and

Medium X can also play a role for the fluid repellency. For example, in order for Object A to slide off from SLIPS by gravity, the density of Object A, px, may desirably be greater than that of the Medium X, p_x (i.e., ρκ > ρχ). Moreover, the size of Object A may be on the order of, or greater than, its capillary length. Specifically, capillary length is a

characteristic length scale that quantifies the dominance of body force over surface force on

1/2

an object, which can be quantitatively expressed as (γ/pg) , where y, p, and g are surface tension and density of the liquid, and gravity, respectively.

[0180] The different parameters noted in (el), (e2) and (e3) (i.e. ΘΑΧ, #BX, 7AX, 7BX, 7AB, R) can be obtained or estimated utilizing the following standard techniques. While the following standard techniques are described, other techniques can be utilized.

[0181] Table 2 A shows examples of working combinations of the solid, Liquids A and B of the slippery surface based on the predictions from the proposed relationship,

R(yBxCOS0Bx - 7AXCOS( AX) + 7AX - 7BX > 0. When the relationship holds, the lubricating liquid will stay in intimate contact with the porous solid without being displaced by Liquid A. Note that the equilibrium contact angles were estimated from the average values of the advancing and receding contact angles of Liquid A and the lubricating liquid on the flat solid surface. Satisfying the relationship can help promote the operation stability of the slippery surface where the liquid layer is substantially completely covered by the test liquid (i.e., two-phase environments that involve a single fluid interface between the test liquid and the liquid layer) and where the liquid layer contacts a droplet of the test fluid as well as air (i.e., three-phase environments that involve three fluid interfaces of (i) test liquid-liquid layer, (ii) test liquid-air, and (iii) liquid layer-air). [0182] In Table 2A, "Y" indicates that Liquid B forms a stable lubricating film, and is not displaced by Object A, and "N" indicates that Liquid B is displaced by Object A. R represents the roughness factor of the substrate, 7A represents the surface tension of Object

A, and 7B represents the surface tension of Object B. ΘΑ and ( B were estimated from the measured static contact angles on flat substrates from at least three individual

measurements (see Table 2B).

Table 2A. Comparison of the Governing Relationships with Experimental Observations for Various Solid-Liquid-A-Liquid-B Combinations.

Solid Liquid Liquid R 7A 7B 7AB Θ_Α Θ_Β Δ£„ ΑΕ₂ Stable Film?

A B Theory Εχρ.

S. Epoxy H₂0 FC-70 2 72.4 17.1 56.0 1 13.1 14.1 45.0 34.0 145.3 Y Υ

S. Epoxy C_l6¾4 FC-70 2 27.2 17.1 8.2 70.5 14.1 7.5 6.8 25.1 Y Υ

S. Epoxy C13H28 FC-70 2 25.9 17.1 7.7 63.5 14.1 5.0 2.4 18.9 Υ Υ

S. Epoxy C10H22 FC-70 2 23.6 17.1 6.7 60.0 14.1 4.8 2.9 16.1 Υ Υ

S. Epoxy CsHig FC-70 2 21.4 17.1 4.4 50.7 14.1 3.0 1.7 10.4 Υ Υ

S. Epoxy C6¾4 FC-70 2 18.6 17.1 2.6 40.1 14.1 2.4 2.1 6.2 Υ Υ

S. Epoxy C5H12 FC-70 2 17.2 17.1 2.5 30.8 14.1 1.8 1.1 3.7 Υ Υ

Epoxy H₂0 FC-70 2 72.4 17.1 56.0 92.6 33.5 17.5 -20.9 90.4 Υ/Ν Υ

Epoxy C_l6¾4 FC-70 2 27.2 17.1 8.2 30.6 33.5 -9.2 -26.5 -8.2 Ν Ν

Epoxy C13H28 FC-70 2 25.9 17.1 7.7 26.9 33.5 -8.8 -25.4 -8.9 Ν Ν

Epoxy C10H22 FC-70 2 23.6 17.1 6.7 14.2 33.5 -8.6 -23.9 -10.7 Ν Ν

Epoxy CsHig FC-70 2 21.4 17.1 4.4 7.9 33.5 -6.9 -18.3 -9.6 Ν Ν

Epoxy C6¾4 FC-70 2 18.6 17.1 2.6 0 33.5 -4.3 -1 1.3 -7.2 Ν Ν

Epoxy C5H12 FC-70 2 17.2 17.1 2.5 0 33.5 -2.9 -8.4 -5.8 Ν Ν

Epoxy H₂0 FC-70 1 72.4 17.1 56.0 92.6 33.5 17.5 -38.5 72.8 Υ/Ν Ν

Epoxy C_l6¾4 FC-70 1 27.2 17.1 8.2 30.6 33.5 -9.2 -17.4 0.9 Υ/Ν Ν

Epoxy C13H28 FC-70 1 25.9 17.1 7.7 26.9 33.5 -8.8 -16.5 0.0 Υ/Ν Ν

Epoxy C10H22 FC-70 23.6 17.1 6.7 14.2 33.5 -8.6 -15.3 -2.1 Ν Ν

¹

Silicon C_l6¾4 H₂0 1 27.2 72.4 51.1 5.6 13.1 43.4 -7.7 -1.8 Ν Ν

Silicon C10H22 H₂0 1 23.6 72.4 50.8 5.0 13.1 47.0 -3.8 -1.8 Ν Ν

Silicon CsHig H₂0 1 21.4 72.4 50.8 5.0 13.1 49.2 -1.6 -1.8 Ν Ν

Silicon C6¾4 H₂0 1 18.6 72.4 50.9 5.0 13.1 52.0 1.1 -1.8 Υ/Ν Ν

Silicon C5H12 H₂0 17.2 72.4

¹ 51.0 5.0 13.1 53.4 2.4 -1.8 Υ/Ν Ν

PDMS Water PDMS 1 72.4 21.3 43 1 10 5.0 46.0 3.0 97.1 Υ Υ

PP Water PDMS 1 72.4 21.3 43 108 5.0 46.0 0.6 94.7 Υ Υ

ΡΡ Water PDMS 2 72.4 21.3 43 108 5.0 43.6 44.2 138.3 Υ Υ

PTFE Water PDMS 2 72.4 21.3 43 1 15 5.0 51.8 60.6 154.7 Υ Υ Table 2B. Measured Contact Angles of Various Liquids on Different Flat Solids.

Liquids

Solids H_?0 Ci 1_fi6HΠ34 Cn 13HΠ22 Cm 10HΠ22 CgHig C_fi 6HΠ14 C,H 12 FC-

S. 0. adv 118.9±1.7 76.3±1.4 72.8±0.2 66.0±4.1 57.7±2.5 52.5±0.3 36.4±2.5 23.7±< statⁱc ii3.i±2.8 70.5±2.0 63.5±2.8 60.0±2.8 50.7±3.0 40.1±4.2 30.8±3.1 14.1±^{( Ep0Xy Θ}. 90.8±0.9 50.0±3.9 48.1 ±3.1 38.5±0.7 23.8±4.0 22.8±1.7 17.0±1.8 0.0±0

Epoxy ⁽ _adv mo_.3±3_.1 32.8±1.4 28.3±1.1 1 .0±1.6 9.7±1.2 -0.0 -0.0 35.1±(

Static 92.6±1.8 30.6±0.4 26.9±1.7 14.2±0.7 7.9±0.7 -0.0 -0.0 33.5±: ^^rec 67.0±4.5 25.7±0.9 25.4±0.7 13.7±0.9 6.1 ±0.2 -0.0 -0.0 26.7±

Silicon 17.3±1.6 7.9±1.0 <5.0 <5.0 <5.0

5.6±1.1 <5.0 <5.0 <5.0 <5.0

~0-0 ~0-0 ^OJl ^OJl

Table 2C. Measured Surface Tension for Various Polar and Non-Polar Liquids.

Liquid Surface Tension (niN/m) n

Watpr 79 4 + n 1 116

Glvre nl f n ± 1 1

F.thvlerie Glvrnl 48 1 ± Ω 9

ninrnnvlerie Glvrnl ± Ω

F.xtra-lipht Cm He Oil* 27 Ω ± Ω 8 1

Tiptit CniHe Oil** 9 f ± Ω 9 1

HexaHerane 27 9 ± Ω 9

Tri Hera rie 9 9 ± Ω 1

DnHerane 7 ± Ω 1 9

TTriHerarie 24 f ± Ω 9 9

Derarie 9 f ± Ω 1 9

Nnnane 22 f ± Ω 9

Ortarie 91 4 ± Ω 9

Hentane 1Q 9 ± Ω 9

Hexarie 18 f ± Ω

Pentarie 17 9 ± Ω 7 FlimrinertTM ρΓ-70 17 1 + 0 1 4^

[0183] Notice that y_A and y_B are equivalent to 7A and y_Bx defined in the text, and

medium X is air specifically in this context. Variable >ΆΒ represents the interfacial tension for Object A-Liquid B interface. Specifically, ^AB for water-perfluorocarbon and

hydrocarbon-perfluorocarbon interfaces were measured by the pendant droplet method (see Table 2D) except the water-hydrocarbon interfaces, which are estimated from the formulation: 7AB = 7A + 7B - ^{rir )^m, where γ_κ ^Α and are the dispersion force contributions of the liquid surface tensions (Fowkes, F. M., Ind. Eng. Chem. 56, 40 - 42, 1964; Israelachvili, J. N. Intermolecular and Surface Forces, Academic Press, 2011). The dispersion force contribution of water surface tension is 21.8 mN/m (Fowkes, F. M., Ind. Eng. Chem. 56, 40 - 42, 1964). S. Epoxy represents silanized epoxy resin substrate.

Alkanes are represented in C_nH_2N+2 where n = 5, 6, 8, 10, 13, and 16.

Table 2D. Measured Interfacial Tension between a Perfluorocarbon and Various

Liquids.

Liquid/Liquid Interfacial Tension (mN/m) n

FC-70/Water 56.0 ± 0.9 12

FC-70/Hexadecane 8.2 ± 0.2 25

FC-70/Tridecane 7.7 ± 0.3 26

FC-70/Decane 6.7 ± 0.2 26

FC-70/Octane 4.4 ± 0.2 25

FC-70/Hexane 2.6 ± 0.1 40

FC-70/Pentane <2.5 10

[0184] Generally, it may be important to have the chemical nature between the roughened solid and the Liquid B be similar. For example, non-polar Liquid B with fluorocarbon functional groups may adhere well with roughened solid surface that is functionalized with fluorocarbon groups (e.g., -CF₃, -CF₂). In another example, polar Liquid B may adhere well with roughened solid surface that is functionalized with hydroxyl groups (i.e., -OH).

[0185] In most of the cases, it may be desirable to have the surface energies of the roughened solid and Liquid B to be lower than the surface energy of Liquid A so that Liquid A will not displace Liquid B from the roughened solid.

[0186] In certain embodiments, when Liquid A is a low surface tension non-polar liquid (e.g., less than 30 mN/m), the roughened surface may be functionalized with low surface energy coatings (e.g., less than 30 mJ/m²), such as -CF₃, -CF₂H, -CF₃ and -CF₂-,

-CF₂-CF₃, -CF₂-CFH-, -CF₂-CH₂- -CFH-CH₂- and the like. Moreover, Liquid B may be selected to also exhibit low surface energy (e.g., less than 20 mJ/m²), such as perfluorotributylamine, perfluorotri-n-pentylamine, perfluorohexane, perfluoro(2-butyl- tetrahydrofuran), perfluorocycloether, perfluoro n-alkyl morpholines, perfluoroalkylethers, perfluorotripropylamine, and the like.

[0187] In certain embodiments, when Liquid A is a high surface tension liquid (e.g., water, condensation) or a solidified fluid, Liquid B can be selected from other higher surface energy fluids (i.e., -20 mJ/m² or higher), such as polydimethylsiloxane, other liquid silicone elastomers or commercial food grade lubricants (e.g., K YTOX(TM) FG lubricants), oils (e.g, vegetable or mineral oil (see FIG. 26B)), and the like. Image (A) in FIG. 26 shows a SLIPS surface generated using an infiltration of polydimethylsiloxane (PDMS) liquid (500 MW, X viscosity, OH-terminated, Sigma Aldrich) into an ePTFE membrane (1 μιη, Sterlitech). Image (B) in FIG. 26 shows a SLIPS surface generated using an infiltration of olive oil into an ePTFE membrane (1 μιη, Sterlitech). In both cases the blood was found to not wet the surface, and rolled off without adhering to the surfaces. In certain embodiments, as with low surface tension liquids, the roughened surface may be functionalized with low surface energy coatings (e.g., less than 30 mJ/m²), such as -CF₃, - CF₂H, -CF₃ and -CF₂- -CF₂-CF₃, -CF₂-CFH- -CF₂-CH₂- -CFH-CH₂- and the like.

[0188] Table 3 shows some non-limiting examples of combinations of substrates, lubricating liquid (Liquid B), and liquid to be repelled (Liquid A). For example, in one embodiment, the solid substrate can be selected from the group consisting of

polydimethylsiloxane, polypropylene, polytetrafluoroethylene, and the like. In this embodiment, lubricating liquids such as liquid silicone elastomers (e.g.,

polydimethylsiloxane), vegetable or mineral oil, liquid hydrocarbons, and combinations thereof can be applied to the solid substrate to create a SLIPS surface to repel materials such as simple aqueous fluids (e.g., water), complex aqueous fluids (e.g., blood), solidified fluids, and combinations thereof (Table 3, row 1).

[0189] In another embodiment, the solid substrate can be selected from the group consisting of fluoro-silanized metals (e.g., fluoro-silanized aluminum, silver, gold, platinum, copper, gold, palladium, zinc, titanium, and the like), fluoro-silanized natural polymers (e.g., fluoro-silanized synthetic polymers (e.g., fluoro-silanized epoxy resin, silicone, silicone rubber, latex, polytetrafluoroethylene, polyvinylfluoride, polyvinylidene fluoride, fluorinated ethylene propylene, thermoplastic elastomers, Teflon, and the like), and combinations thereof. Lubricating liquids such as perfluorinated fluids can be applied these solid substrates to repel any non-perfluorinated liquid (Table 3, row 2).

Table 3. Examples of Combinations of Materials for Making SLIPS Surfaces

[0190] In some embodiments, it may be desirable to have SLIPS that are optically transparent. By choosing a substrate and lubricating fluid with matching refractive indices, SLIPS can be made optically transparent in visible and/or near-infrared wavelengths (FIG. 16A-C). FIG. 16A shows optical images showing enhanced optical transparency of an epoxy-resin-based SLIPS (left) as compared to significant scattering in the non-infused super hydrophobic nanostructured surface (right) in the visible light range. FIG. 16B. shows optical transmission measurements for epoxy-resin-based SLIPS in the visible light range (400-750 nm). FIG. 16C shows optical transmission measurements for Teflon-based SLIPS in the near-infrared range (800-2300 nm).For example, FIG. 64 shows images of a transparent SLIPS surface made by the infiltration of a highly-ordered nanoporous Si02 glass layer (A) with perfluorocarbon (FC-70) (B). When fully infiltrated, the layer is highly transparent (C).

Measurement of Θαχ, Advancing and Receding Angles, Static Angles

[0191] The behavior of liquids on surfaces is described by an equilibrium contact angle.

An equilibrium contact angle, θ, is the angle at which a liquid/vapor interface meets a solid surface, which is determined by the interactions across the three interfaces, e.g.,

solid/liquid/vapor. Experimentally, the most stable equilibrium contact angle of a liquid droplet on a real surface can be difficult to attain. Liquid droplets sitting on the surface exhibit a variety of contact angles bound by two extreme values. The upper limit is known as the apparent advancing contact angle ((9A), whereas the lower limit is referred as the apparent receding contact angle (9R). The difference between these values is known as contact angle hysteresis (i.e., Αθ = ΘΑ - <9R, where ΘΑ≥ θ> 9R), which characterizes the liquid repellency of a surface. Conventionally, equilibrium contact angle can be roughly estimated by the average of the advancing and receding angles (i.e., θ = (ΘΑ + 9R)/2), or by a static contact angle, ⁽ _static (i.e., Θ = ⁽9_static).

[0192] In practice, contact angle measurement can be performed by a number of different well-established techniques, such as the sessile drop method and the Wilhelmy method. In particular, the sessile drop method is among the most popular technique for contact angle measurement. In this technique, a liquid droplet is deposited on a targeted solid surface, where the liquid profile is captured by an optical system of a goniometer and geometrically fitted to obtain the contact angle. The contact angle measured from a static liquid droplet deposited on the surface is known as the static contact angle, ( _static. Using the same system, advancing contact angle, (9A, can be measured while the volume of the drop is increasing until the wetting line starts to advance. Receding contact angle, (9R, can be measured by decreasing the volume of the drop and determining the contact angle just before the wetting line recedes. Alternatively, the advancing and the receding angles of the liquid drop can also be determined by gradually tilting the solid surface until the liquid drop starts to move.

Measurement of Fluid-Fluid Interfacial Tension: AX, y_Bx, AB

[0193] Fluid-fluid interfacial tension can be measured by many well-established techniques, such as the Wilhelmy plate method, the Du Noiiy ring method, and the pendant drop method (e.g., see Drelich et al., in Encyclopedia of Surface and Colloid Science, pp. 3152 - 3166, Marcel Dekker Inc, 2002, the contents of which is incorporated by reference herein in its entirety). Among all of the techniques, the pendant drop method is among the most popular and versatile technique, which can be easily extended to a two-liquid system. The pendant drop method measures the shape of a fluid-fluid interface and quantifies the shape distortion due to the competition between the fluid- fluid interfacial tension and gravity. In practice, a drop of denser fluid (e.g., Object A) is suspended by a syringe needle in medium X (i.e., air/water/the lubricating fluid). Owing to the influence of gravity, the denser liquid droplet will be deformed as the liquid volume increases. The shape profile of the liquid droplet is captured by an optical system and subsequently analyzed by a computer software when the liquid volume is increased to the maximum possible size (i.e., before the liquid drop is detached from the syringe needle). The interfacial tension of the fluid-fluid interface, y, can then be deduced from the formula, y = ApgD²/H, where Ap is the density difference between the two immiscible fluids, g is gravity, D is equatorial diameter of the liquid droplet, and H is drop shape dependent parameters which is a function of the shape profile of the droplet.

Measurement of Surface Roughness: R

[0194] Roughness of a surface can be quantitatively estimated by a number of indirect and direct approaches. For example, one of the simplest indirect methods to quantify surface roughness is the use of Wenzel's relationship to estimate the roughness by measuring the apparent contact angle of a surface. Specifically, the Wenzel's relationship can be described by the formula, cos( * = Rcos9, where Θ* and Θ are the measured apparent contact angle of the roughened surface, and the equilibrium contact angle of a substantially flat surface (of same material), respectively.

[0195] For direct measurements, the surface roughness can be quantitatively measured by using an atomic force microscope or by a scanning electron microscope. Specifically, the use of atomic force microscope (AFM) allows for simple, and direct 3 -dimensional mapping of the surface morphology. In practice, a suitable AFM probe is selected for the measurements depending on the aspect ratio of the surface features (note: aspect ratio is defined as the ratio between the height and the width of the surface features). As a rule of thumb, sharp AFM probes (i.e., radius of tip curvature < 10 nm) of very high aspect ratio (i.e. > 10) would allow for relatively precise measurements of surfaces with general morphologies. Alternatively or in addition, the use of scanning electron microscope can also be used for the measurement of the top view and cross sectional view of the surface morphologies for the estimation of the surface roughness.

[0196] In certain embodiments, the roughness of a 3-D porous material can be estimated by measuring the surface morphology of the top-most layer of the porous material. Particularly, the estimation may be particularly well-suited when complete wetting of a surface is predominately induced by the roughness at the surface layer of the material that is in intimate contact with the fluid.

[0197] In some embodiments in which SLIPS is used to repel complex biological fluids without permitting adhesion, clot formation, or fouling, the lubricating fluid is an organofluorine oil, (i.e., perfluorinated oils including, without limitation, tertiary perfluoroalkylamines (such as perfluorotri-n-pentylamine, FC-70; perfluorotri-n- butylamine FC-40, etc), perfluoroalkylsulfides, perfluoroalkylsulfoxides,

perfluoroalkylethers, perfluorocycloethers (like FC-77), perfluoropolyethers (such as K YTOX family of lubricants by DuPont), perfluoroalkylphosphines, and

perfluoroalkylphosphineoxides) .

[0198] In certain embodiments, the slippery surface of the present disclosure has a coefficient of friction that is lower than polytetrafluoroethylene (PTFE or TEFLON). In certain embodiments, the coefficient of friction is less than 0.1, less than 0.05, or even less than 0.04. In certain embodiments, the coefficient of friction can be measured against polished steel, Teflon, or the slippery surface of the present disclosure itself (e.g., slippery surface/slippery surface).

[0199] As shown in FIGS. 27A and 27B, there are two working configurations for the invention. In the first configuration, as shown in FIG. 27A, the lubricating liquid (Liquid B) overcoats the roughened solid surface, and forms an ultra- smooth surface. Liquid B can wet the roughened surface, filling the hills and valleys of the roughened surface, and forming an ultra-smooth surface over the roughened surface. Particularly, Liquid B can form a liquid layer over the roughened surface so that the liquid layer covers the roughened surface to form an ultra- smooth surface of Liquid B (FIGS. 6 A and 6B). In certain embodiments, the average surface roughness of the surface is on the order of or less than about 1 nm based on high resolution atomic force microscopy measurements. The presence of the micro/nanostructures can significantly enhance the wetting of Liquid B, thereby creating a uniformly-coated slippery functional layer over the topographies. The first configuration may be useful for repelling a liquid, gas, or molecules or particulates contained within liquids.

[0200] In the second configuration shown in FIG. 27B, the lubricating fluid (Liquid B) infiltrates within the solid textures, forming a composite solid-liquid interface. Rather than forming the ultra-smooth surface of FIG. 27A the lubricating fluid (Liquid B) can infiltrate the roughened solid surface and form a thin coating thereon that follows the topography of the underlying roughened solid surface. In certain embodiments, the thin coating may be conformally coating the top surface of the roughened surface. As used herein, "conformal coating" can encompass forming a molecular monolayer or multiple molecular layers that surround the materials of the roughened surface. However, the "conformal coating" is not thick enough to form an over-coat layer to form an ultra-smooth surface, such as described in FIG. 27A. In certain embodiments, the second configuration may be particularly useful for repelling materials in their solid forms.

[0201] In order for the lubricating fluid (Liquid B) to remain attached with the roughened surface, at least the following three properties are desirable: (1) the lubricating fluid (Liquid B) readily imbibes into, wets, and stably adheres within the substrate, (2) the roughened surface is preferentially wetted by the lubricating fluid (Liquid B) rather than by the material to be repelled, and (3) the lubricating fluid (Liquid B) and the material to be repelled are immiscible.

Object A and Lubricating Liquid Combinations

[0202] In certain embodiments, the solidification temperature of the lubricating liquid may be lower than that of Liquid A. In certain embodiments, the lubricating liquid can maintain its liquid state below the solidification temperature of Liquid A, thereby retaining its slippery property. Without wishing to be bound by theory, there may be at least two reasons to maintain the lubricating liquid in a liquid state even while Liquid A solidifies.

[0203] First, having the lubricating liquid maintained in the liquid state may result in reduced adhesion at the interface between Object A and the lubricating liquid in the directions normal and tangential to the substrate surface, as compared to that of the interface between the solidified form of the material to be repelled and other solid surfaces (i.e., roughened surfaces). Adhesion between surfaces may be proportional to the contact surface area, where the smoothness of the lubricating liquid surface can minimize contact area between Object A and the lubricating liquid, due to the smaller surface area at the interface compared to a roughened surface. The reduced adhesion may facilitate removal of Object A from the lubricating liquid surface at much reduced force per unit area.

[0204] Second, the ultra-smooth surface of the lubricating liquid may also reduce the condensation of Liquid A from the air (i.e., assuming the vaporized form of Liquid A is present in air) when the surface of the lubricating liquid is cooled to the temperature below the solidification temperature of Liquid A. This may be due to the fact that there are few or even no nucleation sites on the lubricating liquid surface, which greatly reduce the nucleation probability of the repelled liquid. As a result, the formation of fog and frost (i.e., solidified form of the repelled liquid at the micro- and nanoscale) on the surface can require more stringent conditions (e.g., lower temperature or a higher vapor pressure of Liquid A in the air) as compared to the other solid surfaces. To maintain the lubricating liquid in the liquid state, the solidification temperature of the lubricating liquid may be 25

C lower than that of Liquid A at atmospheric pressure.

[0205] In certain embodiments, the boiling temperature of the lubricating liquid may be higher than the solidification temperature of Liquid A. In certain embodiments, the lubricating liquid may be able to maintain its liquid state above the solidification temperature of Liquid A. Additionally, maintaining the liquid state may facilitate the removal of Liquid A from the lubricating liquid surface due to the aforementioned liquid- slippery function, while the surface is held at a temperature above the solidification temperature of Liquid A. This may be particularly important for applications in surface defrosting, where the lubricating liquid may be defrosted using minimal energy input (e.g., at a lower temperature) as compared to other solid surfaces. To maintain the lubricating liquid in the liquid state, the boiling temperature of the lubricating liquid may be 215 °C higher than the solidification temperature of Liquid A at atmospheric pressure.

[0206] In certain embodiments, the solid to be repelled (or Object A) may slide off from the surface of the lubricating liquid by gravity when the surface is tilted at an angle with respect to the horizontal, given that Object A is larger than a characteristic size.

Specifically, the effect of gravity on Object A may be more dominant when its size is much larger than the capillary length of Liquid A. Specifically, capillary length is a characteristic length scale that quantifies the dominance of body force over surface force on an object,

1/2

which can be quantitatively expressed as (γ/pg) , where y, p, and g are surface tension and density of the liquid, and gravity, respectively. For example, Object A may be at least 3 times larger than the capillary length of Liquid A.

[0207] In certain embodiments, the lubricating liquid may be selected to satisfy additional criteria needed for Solid A or Object A. For example, when Object A is a biological object, the lubricating liquid can be selected so that the lubricating liquid is not toxic to Object A so that facile transport of Object A to desired locations without reducing the biological activity of Object A. In another example, the lubricating liquid can be selected so that the lubricating liquid is toxic to Object A so that removal of Object A can be further coupled with reducing the biological activity of Object A.

Certain Advantages for Porous Material [0208] In certain embodiments, use of a porous material having a high degree of physical roughness for the roughened surface may be particularly advantageous. The presence of such physical roughness may induce not only the complete wetting of the lubricating fluid, but also provide additional capillary adhesion for the lubricating fluid within the porous solid to further enhance the mechanical stability, wicking characteristics and the ability to "hold" Liquid B "in place" even at high tilt angles.

[0209] Moreover, another important feature for the use of porous material may be that further structuring of the surface may not be needed, since the physical structures are already embedded within the bulk material. In such cases, the porous material can be a self-supporting, free-standing membrane which can be attached/glued/adhered to the external or internal surfaces of materials with any kind of geometry (see FIGS. 7 and 8).

[0210] In addition, one of the unique features of using porous materials may be the presence of the capillaries network within the bulk materials, which can further enhance transport of Liquid B through the pores. For example, in the case where a portion of Liquid B is consumed locally at the surface of the material due to evaporation, sudden pressure purging, physical damage or the like, Liquid B can be replenished effectively by the capillary action in these networks. In certain embodiments, the porous material itself can be utilized as a fluid reservoir to store the fluorinated liquid for subsequent capillary refilling (see FIG. 8).

[0211] In certain embodiments, to further prolong the life time of the slippery surface of the present disclosure, the porous material can also be connected to an external fluid reservoir or larger storage capacity, where the capillary networks can help autonomously transfer the liquids from the fluid reservoir to the bulk material itself (see FIG. 8).

[0212] In certain embodiments, the pore size of the porous material can roughly be on the order of the capillary length of Liquid B or smaller. Such size may allow stabilizing

Liquid B in the porous material. Capillary length, _c, can be defined as A_c =

, where γ is the surface tension of Liquid B, p is the density of Liquid B, and g is gravity.

[0213] Taking the exemplary case of utilizing fluorinated liquids as Liquid B, the surface tension of fluorinated liquids is in the range of about 10 - 20 mN/m at a typical density of about 1800 kg/m³. Typical pore sizes can range from about 50 nm to about 100 μιη or up to about 1 mm, such as about 750 um - 1 mm. [0214] In certain embodiments, use of a porous material for the roughened surface may provide even higher resistance to pressure change than the high pressure changes that can be obtained using solid surfaces having certain topographies. For example, while a 2.5D (vertically extruded) nanostructured structure shown in FIG. 5A may be able to sustain a maximum rate of pressure change on the order of 10⁵ Pa per second, use of a porous material (e.g., Teflon membrane) may be able to tolerate pressure change up to about 6 x 10⁶ Pa per second without displacing Liquid B. Without wishing to be bound by theory, the improved pressure tolerance of the 3D porous material can be attributed to the enhanced capillary interactions between the intricate 3D porous network and Liquid B.

[0215] In certain embodiments, use of a porous material for the roughened surface may provide even higher pressure stabilities than the high pressure stability that can be obtained using solid surfaces having certain topographies (e.g., "2.5D" nanostructured surface). For example, use of a porous material (e.g., Teflon membrane) may be able to tolerate absolute pressure up to about 6.9 x lO⁷ Pa while maintaining its liquid slippery function. Without wishing to be bound by theory, the improved pressure tolerance of the 3D porous material can be attributed to the incompressibility of the lubricating layer, as well as the resistance of liquid penetration into the porous structure.

Prevention or Reduction of Microbial Attachment and Biofilm Formation

[0216] Materials (Object As) that can be repelled by SLIPS include microbes such as bacteria. Bacteria primarily exist in robust, surface-associated communities known as bio films, which are ubiquitous in both natural and anthropogenic environments.

Contamination of surfaces by microbial attachment occurs easily, and is the first step towards the development of bacterial bio films as multicellular communal super-organisms (De Beer, D. & Stoodley, P. Microbial Biofilms. Prokaryotes 1 :904-937 (2006); O'Toole, G., Kaplan, H.B. & Kolter, R. Biofilm Formation as Microbial Development. Annu. Rev. Microbiol. 54:49-79 (2000)). Mature biofilms resist a wide range of antimicrobial treatments and pose persistent pathogenic threats.

[0217] Bacteria can physically attach to a vast variety of surfaces - from hydrophilic to hydrophobic, by a variety of mechanisms (O'Toole et al, 2000; De Beer et al, 2006;

O'Toole 2003; Christensen et al, 1985; Costerton et al, 1987; Gristina, 1987; Jacques et al., 1987). The typical mechanisms include an initial deposition of proteins, known as conditioning layer, by physical or chemical adsorption, which precedes the attachment of the bacteria itself. Conditioning films, which may contain fibronectin, fibrinogen, collagen, and other proteins, coat a biomaterial surface almost immediately and provide receptor sites for bacterial or tissue adhesion (Gristina, 1987).

[0218] Bio film formation is of concern to industry and healthcare because it causes contamination of plumbing, oil wells, heat exchangers, building ventilation, food storage, medical implants, and other systems. Biofilms threaten human health by triggering an immune response, releasing harmful endotoxins and exotoxins, and clogging indwelling catheters; in fact, biofilms are responsible for nearly 100,000 nosocomial deaths annually in the United States and 80% or more of all microbial infections in humans.

[0219] Treatment or removal of adherent bio film is difficult, costly, and in medical systems is frequently impossible. It is imperative to prevent rather than treat biofilm formation, and accordingly a wide range of bacteria-resistant surfaces have been proposed. At the same time, strategies for biofilm prevention based on surface chemistry treatments have been found to only transiently affect initial attachment. Most current strategies for preventing biofilm formation rely either on a release of biocidal compounds or on inhibiting adhesion (Banerjee, I., R.C. Pangule, and R.S. Kane, Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Advanced Materials, 2011; Zhao, L., et al., Antibacterial coatings on titanium implants. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009. 91(1): p. 470-480).

[0220] In the first case, traditional techniques involve the design of coatings that release agents such as antibiotics, quaternary ammonium salts, and silver ions into the surrounding aqueous environment. Such agents have been incorporated into a variety of engineering polymers and other materials (Banerjee (2011)).

[0221] The latter approach has focused on the use of surface chemical functional groups that inhibit protein adsorption as a means to inhibit bacterial adhesion. One of the most commonly studied such surface modifications is poly(ethylene glycol), or PEG (Park, K.D., et al., Bacterial adhesion on PEG modified polyurethane surfaces. Biomaterials, 1998. 19(7-9): p. 851-859; Prime, K.L. and G.M. Whitesides, Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces. Science (New York, NY), 1991. 252(5010): p. 1164.)). [0222] More recently, structured superhydrophobic surfaces have been suggested for preventing biofilm attachment owing to the trapped air between their micro/nanoscale surface features and therefore, in principle, the reduced available solid attachment area for biofilm (see, e.g., U.S. Patent Application No. 61/434,217, filed on January 19, 2011, which is incorporated herein in its entirety).

[0223] These strategies, however, are generally transient. Materials that persistently resist bacteria are difficult to achieve by surface chemistry alone. The surface chemistry is subject to desorption over time, a limitation that has driven much research in the area of strengthening the physisorption of, e.g., PEG coatings (Banerjee (2011). However, even if no desorption occurs and bacteria are unable to attach directly to a substrate, nonspecific adsorption of proteins and surfactants secreted by bacteria can still mask the underlying chemical functionality (Bos, R., et al., Retention of bacteria on a substratum surface with micro patterned hydrophobicity. Ferns Microbiology Letters, 2000. 189(2): p. 311-315). Additionally, any defects or voids in the surface chemistry could serve as nucleation sites for bacterial attachment. Structured superhydrophobic surfaces in the Cassie (trapped air) state are prone to irreversible wetting (Wenzel transition), especially with the production of bacterial surfactant, which seriously limits their lifetime in submerged environments (Poetes, Pv., et al., Metastable Underwater Superhydrophobicity. Physical Review Letters, 2010. 105(16)).

[0224] Strategies involving leaching of biocides are limited over a longer timescale since their reservoir is finite and subject to depletion (Zhao, L., et al, Antibacterial coatings on titanium implants. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009. 91(1): p. 470-480). Also, the emergence of antibiotic- and silver- resistant pathogenic strains, along with new restrictions on the use of biocide-releasing coatings in the marine environment, has necessitated the development of new strategies (Hall-Stoodley, L., J.W. Costerton, and P. Stoodley, Bacterial biofilms: from the natural environment to infectious diseases. Nature Reviews Microbiology, 2004. 2(2): p. 95-108; Trevors, J., Silver resistance and accumulation in bacteria. Enzyme and Microbial Technology, 1987. 9(6): p. 331-333; Costerton, J., P. Stewart, and E. Greenberg, Bacterial biofilms: a common cause of persistent infections. Science, 1999. 284(5418): p. 1318.).

[0225] Systemic and topical antimicrobial products have become extensively used to combat biofilm contamination in health care, agriculture, and industrial settings, and increasingly by the general public as well. Commercial products employ a wide variety of active chemical agents, or biocides, often delivered in liquid form and sometimes as vapor. One review of antiseptics and disinfectants identifies 12 classes of liquid agents and 5 common types of vapor-phase sterilants. Regardless of the particular chemistry or mechanism, biocides must be able to reach the target cell to cause damage. At the multicellular level, therefore, the effective biocide must penetrate into the extracellular matrix (ECM)— the slime-like "cement" of bio film. Bio films, however, offer their member cells protection from environmental threats. It has been reported that ECM acts as a diffusion barrier and as a charged binding filter for certain antibiotics, and that it complements enzymes and multidrug resistance pumps on cells that remove antimicrobials. The resistance to threats covers a wide range of treatments: bio films exposed to chlorine bleach for 60 minutes are reported to still have live cells; biofilms in pipes continuously flushed over 7 days with multiple biocides recolonize the pipes, and biofilms have been reported to survive in bottled iodine solution for up to 15 months. Biofilms' resistance to antimicrobials may be related to the extreme nonwettability of their surface as well as resistance to vapor penetration.

[0226] SLIPS can repel various types of bacteria and prevent bio film formation. SLIPS can repel, or prevent or reduce attachment of bacteria suspended in solution, airborne bacteria, and the like. In one embodiment, the type of bacteria repelled by SLIPS is gram positive bacteria. In another embodiment, the type of bacteria repelled by SLIPS is a gram negative bacteria. Non- limiting examples of bacteria repelled by SLIPS include members of the genus selected from the group consisting of Actinobacillus {e.g., Actinobacillus actinomycetemcomitans), Acinetobacter (e.g., Acinetobacter baumannii), Aeromonas, Bordetella (e.g., Bordetella pertussis, Bordetella bronchiseptica, and Bordetella

parapertussis), Brevibacillus, Brucella, Bacteroides (e.g., Bacteroides fragilis),

Burkholderia (e.g., Burkholderia cepacia and Burkholderia pseudomallei), Borelia (e.g., Borelia burgdorferi), Bacillus (e.g., Bacillus anthracis and Bacillus subtilis),

Campylobacter (e.g., Campylobacter jejuni), Capnocytophaga, Cardiobacterium (e.g., Cardiobacterium hominis), Citrobacter, Clostridium (e.g., Clostridium tetani or

Clostridium difficile), Chlamydia (e.g., Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psiffaci), Eikenella (e.g., Eikenella corrodens), Enterobacter, Escherichia (e.g., Escherichia coli), Francisella (e.g., Francisella tularensis), Fusobacterium, Flavobacterium, Haemophilus {e.g., Haemophilus ducreyi or Haemophilus influenzae), Helicobacter (e.g., Helicobacter pylori), Kingella (e.g., Kingella kingae), Klebsiella (e.g., Klebsiella pneumoniae), Legionella (e.g., Legionella pneumophila), Listeria (e.g., Listeria monocytogenes), Leptospirae, Moraxella (e.g., Moraxella catarrhalis), Morganella, Mycoplasma (e.g. , Mycoplasma hominis and Mycoplasma pneumoniae), Mycobacterium (e.g. , Mycobacterium tuberculosis or Mycobacterium leprae), Neisseria (e.g., Neisseria gonorrhoeae or Neisseria meningitidis), Pasteur ella (e.g. , Pasteur ella multocida), Proteus (e.g., Proteus vulgaris and Proteus mirablis), Prevotella, Plesiomonas (e.g., Plesiomonas shigelloides), Pseudomonas (e.g., Pseudomonas aeruginosa), Providencia, Rickettsia (e.g., Rickettsia rickettsii and Rickettsia typhi), Stenotrophomonas (e.g., Stenotrophomonas maltophila), Staphylococcus (e.g., Staphylococcus aureus and Staphylococcus epidermidis), Streptococcus (e.g., Streptococcus viridans, Streptococcus pyogenes (group A),

Streptococcus agalactiae (group B), Streptococcus bovis, and Streptococcus pneumoniae), Streptomyces (e.g., Streptomyces hygroscopicus), Salmonella (e.g., Salmonella enteriditis, Salmonella typhi, and Salmonella typhimurium), Serratia (e.g., Serratia marcescens), Shigella, Spirillum (e.g., Spirillum minus), Treponema (e.g., Treponema pallidum), Veillonella, Vibrio (e.g., Vibrio cholerae, Vibrio parahaemolyticus, and Vibrio vulnificus), Yersinia (e.g., Yersinia enter ocolitica, Yersinia pestis, and Yersinia pseudotuberculosis), Xanthomonas (e.g., Xanthomonas maltophilia) and combinations thereof.

[0227] In particular, SLIPS has been shown to prevent 99.6% of common bacterial biofilm attachment under both flow and static conditions, which represents at least a 30x reduction in biofilm attachment over best-case-scenario, state-of-the-art surface treatments based on PEGylation.

[0228] Moreover, SLIPS can repel various types of fungi. Non-limiting examples of fungi repelled by SLIPS include members of the genus Aspergillus {e.g., Aspergillus flavus, Aspergillus fumigatus, Aspergillus glaucus, Aspergillus nidulans, Aspergillus niger, and Aspergillus terreus), Blastomyces dermatitidis, Candida {e.g., Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, and Candida guillermondii), Coccidioides immitis, Cryptococcus {e.g., Cryptococcus neoformans, Cryptococcus albidus, and Cryptococcus laurentii), Histoplasma capsulatum var.

capsulatum, Histoplasma capsulatum var. duboisii, Paracoccidioides brasiliensis, Sporothrix schenckii, Absidia corymbifera; Rhizomucor pusillus, Rhizopus arrhizous, and combinations thereof.

[0229] SLIPS can also repel various types of viruses and virus-like particles. In one or more embodiments, the virus repelled by SLIPS is selected from the group consisting of dsDNA viruses, ssDNA viruses, dsRNA viruses, (+)ssRNA viruses, (-)ssRNA viruses, ssRNA-PvT viruses, dsDNA-RT viruses, and combinations thereof. Non-limiting examples of viruses repelled by SLIPS include cytomegalovirus (CMV), dengue, Epstein-Barr, Hantavirus, human T-cell lymphotropic virus (HTLV I/II), Parvovirus, hepatitides (e.g., hepatitis A, hepatitis B, and hepatitis C), human papillomavirus (HPV), human

immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), respiratory syncytial virus (RSV), Varicella zoster, West Nile, herpes, polio, smallpox, yellow fever, rhinovirus, coronavirus, Orthomyxoviridae (influenza viruses) {e.g., Influenzavirus A, Influenzavirus B, Influenzavirus C, Isavirus and Thogotovirus), and combinations thereof.

[0230] In still another embodiment, SLIPS is capable of repelling particles in suspension or solution without causing surface adhesion, surface-mediated clot formation, fouling, or aggregation. The omniphobic nature of SLIPS allows it to protect surfaces from a wide range of contaminants. Non- limiting examples of a particles in suspension or solution include cells (e.g., normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, stem cells, and infected cells), microorganisms (e.g., viruses, virus-like particles, bacteria, bacteriophages), proteins and cellular components (e.g., cell organelles, cell fragments, cell membranes, cell membrane fragments, viruses, virus-like particles, bacteriophage, cytosolic proteins, secreted proteins, signaling molecules, embedded proteins, nucleic acid/protein complexes, nucleic acid precipitants, chromosomes, nuclei, mitochondria, chloroplasts, flagella, biominerals, protein complexes, and minicells).

[0231] In other embodiments, SLIPS repels natural and synthetic solutions used in medicines, intravenous solutions, pharmaceutical manufacturing, and medication delivery systems.

Prevention of or Reduction Protein Adsorption

[0232] In one embodiment, SLIPS is used to prevent or reduce protein adsorption.

[0233] Biocompatibility and contamination issues associated with the contact of foreign surfaces involve nonspecific protein adsorption. Biocompatibility is the ability of a material to allow an appropriate host response in a specific environment or application. In general, foreign surfaces of medical instruments and medical devices attract a variety of biological adsorption events and biological responses, and it is very difficult to prevent, reduce, or control these processes (Ratner (Ed.), Biomaterials Science, Academic Press (2004)).

There is a complex variety of biological responses to foreign surfaces, in vivo and ex vivo, associated with biofouling events, immune response, protein adsorption, thrombus formation, and the like (Ratner (Ed.), Biomaterials Science, Academic Press (2004)).

Proteins have an inherent tendency to deposit on surfaces as a tightly bound adsorbate, which strongly influences subsequent cellular (or microbial) interactions with the surface (Ratner (Ed.), Biomaterials Science, Academic Press (2004)). Bacteria attach to surfaces by means of a conditioning layer of proteins. Implanted biomaterials or medical devices are rapidly coated by constituents of the blood serum and surrounding matrix, which include fibronectin, osteonectin, vitronectin, albumin, fibrinogen, laminin, collagen and covalently-bound short-chain oligosaccharides (Ratner (Ed.), Biomaterials Science, Academic Press (2004); Gristina, A.G., et al., Biomaterial-centered sepsis and the total artificial heart. Microbial adhesion vs tissue integration. JAMA 259:870-874 (1988)). Both bacteria and tissue cells can then attach to these various proteins.

[0234] Protein adsorption also occurs when devices trigger an immune response in the body. When the immune response is triggered, complement proteins opsonize the foreign surface for phagocytosis. Complement activation leads to deposition of complement components, which foul the foreign surface (Skattum L, et al, Mol. Immunol, 48(14): 1643- 55 (2011)).

[0235] To date, surface modifications such as the attachment of antithrombotic agents (heparin) or the immobilization of polyethylene oxide (PEO) or polyethylene glycol (PEG) have been thoroughly tested, but their success at avoiding protein adsorption remains limited (George, P. A., et al, J.J. Self-assembling polystyrene-block-poly(ethylene oxide) copolymer surface coatings: resistance to protein and cell adhesion. Biomaterials 30: 2449- 2456 (2009)). Although PEG-based surfaces resist non-specific protein adsorption and cell adhesion, they eventually oxidize in most biochemical environments (Ratner (Ed.), Biomaterials Science, Academic Press (2004); Chen, S., et al. Surface hydration: Principles and applications toward low-fouling/non-fouling biomaterials. Polymer 51 :5283-5293 (2010)). The non- fouling properties of antifouling materials is generally caused by a tightly-bound water layer acts as a physical and energetic barrier to protein adsorption. Chen, S., et al. Polymer 51 :5283-5293 (2010). However, these surfaces eventually deteriorate and allow adsorption to occur.

[0236] Thus, in one or more embodiments, SLIPS can be used to prevent or reduce adsorption of proteins that come into contact with SLIPS.

Preventing or Reducing Adhesion of Biological Fluids

[0237] Fluids such as biological fluids that are applied to, or come into contact with, SLIPS are strongly repelled by the lubricating fluid. As used herein, "fluids" includes fluids and particles in suspensions or solution, including those from living organisms and synthetic solutions used in medicines.

[0238] This surface design represents a completely new approach to controlling the adhesion of biological fluids. Non-limiting examples of biological fluids that can be repelled by SLIPS without causing surface adhesion or aggregation include whole blood, serum, plasma, water, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, synthetic fluid (e.g., synthetic blood, hormones, nutrients), and combinations thereof.

Applications for SLIPS

Anticoagulation Surface

[0239] Surfaces that prevent or reduce blood coagulation by repelling blood components, such as platelets and fibrin, involved in the clotting cascade mechanism, can be made in accordance with the present disclosure. In one embodiment, SLIPS is applied to a medial device that comes into contact with complex fluids such as blood to create an anti-coagulation surface. Blood clotting on synthetic surfaces is a long-standing and widespread problem in medicine (Thompson, A.R. & Harker, L.A. Manual ofHemostasis and Thrombosis, (F. A. Davis, Philadelphia, 1983); Colman, R.W., Hirsch, J., Marder, V.J. & Salzman, E.W. (eds.). Hemostasis and Thrombosis, (Lippincott Williams and Wilkins, 2005)). Thrombosis is initiated on surfaces first by protein absorption, which promotes platelet adhesion, activation and release of thrombin that cleaves fibrinogen and activates fibrin clot formation ((Thompson, A.R. & Harker, L.A. Manual of Hemostasis and Thrombosis, (F. A. Davis, Philadelphia, 1983); Colman, R.W., Hirsch, J., Marder, V.J. & Salzman, E.W. (eds.). Hemostasis and Thrombosis, (Lippincott Williams and Wilkins, 2005))).

[0240] Results demonstrate that SLIPS does not allow blood to wet, and adhere to, SLIPS. Anti-coagulant surfaces that prevent or reduce blood coagulation can be developed by creating an ultra-low drag clot-free surface, much like living endothelium does (see Example 2).

[0241] Anti-coagulation surfaces disclosed herein represent a novel and surprisingly effective method for controlling the adhesion of blood components, such as platelets and fibrin, involved in the clotting cascade mechanism. Anti-coagulation surfaces do not allow blood to wet, or adhere to, SLIPS by creating an ultra-low drag clot free surface, much like living endothelium does. FIG. 1 shows the porous or rough layer with the low surface energy, chemically inert, perfluorinated liquid, infiltrated around it. The perfluorinated oil may be held in place by the features of SLIPS structures. This combination leads to a physically smooth, ultra-repellant, and chemically homogeneous lubricating film on the surface of the substrate because the porous structure holds the low energy fluid in place. The presence of the physical roughness of the porous material not only induces the complete wetting of the lubricating fluid, but can also provide additional adhesion for the lubricating fluid within the porous solid. Thin lubricating film minimizes surface inhomogeneities, reduces retention forces, and enhances fluid mobility along SLIPS, not unlike the lipid bilayer in the endothelial cell membrane. As a result, the drag forces on fluid in contact with SLIPS are minimal, and the fluid remains highly mobile on SLIPS. The lubricating film is generated through a fluid infiltration process induced by the porous materials.

[0242] In one or more aspect of the disclosed embodiments, SLIPS supports blood flow at 100 mL/hr for 1, 2, 3, 4, 5, or 10 hours or more without platelet activation or clotting. In other aspects, SLIPS supports blood flow at 500 mL/hr for 8, 10, 15, or 20 hours or more without platelet activation or clotting. In still other aspects, SLIPS supports blood flow at 1000 mL/hr for 12, 15, 20, or 24 hours or more without platelet activation or clotting. In other aspects, SLIPS supports blood flow at 1250 mL/hr for 24, 36, or 48 or more hours without platelet activation or clotting. In still other aspects, SLIPS supports blood flow at 1250 mL/hr for a period of days, months, or years.

Medical Devices

[0243] In other embodiments, SLIPS is incorporated into medical devices to prevent or reduce adhesion of proteins, microbes, blood, tissue, and the like.

[0244] Foreign surfaces associated with medical devices used in biomedical

environments are commonly contaminated with bacterial, viral, and fungal microorganisms. Contaminated medical-device surfaces can develop into persistent biofilm infection, and cause infection in other places of the body (Ratner (Ed.), Biomaterials Science, Academic Press (2004)). Currently, there are no materials that can prevent, delay, or reduce biological processes associated with protein adsorption, bacterial attachment, and inflammation response. Many materials or coatings, such as heparinized surfaces and Teflon (PTFE), prevent biochemical attachment and response by chemical or biochemical means. Because such materials and coatings rely on chemical or biochemical means to prevent biochemical attachment and response, the use of these materials is limited to certain environments. Moreover, the ability of these materials to repel fluids is limited to certain biological species.

[0245] Medical devices and biomedical implants in the body can cause injury to the tissue surrounding the device or implant. Inflammation, wound healing, plaque disposition, and foreign body response are common reactions to these injuries. Medical devices and implants can cause chronic inflammation, formation of granulation tissue, and an end-stage healing response of fibrosis or fibrous encapsulation (Ratner (Ed.), Biomaterials Science, Academic Press (2004)). However, no device or coating exists that prevents these injuries from occurring.

[0246] Various attempts have been made to coat catheter surfaces with nontoxic antiseptic or antimicrobial drug, or to incorporate such a substance into the catheter material itself (Crnich et al., 2002). These anti-bacterial surfaces have been based on the principle of incorporating compounds such as Ag-particle composite structures, antiseptics, and antibiotics. However, these approaches are ultimately limited in their effectiveness due to the limitations antibiotic species to diffuse from the material, as demonstrated in the large number of infections associated with medical instruments (Crnich 2002, Gristina 1987).

[0247] For example, catheters, cannulas, and shunts are commonly used inside and outside the body to allow drainage, administration of fluids or gases, or access by surgical instruments. They can be temporary or permanent {e.g., indwelling catheter). These medical devices can be made of a range of polymers, including silicone rubber, latex, and thermoplastic elastomers. Bacterial infection and colonization of catheters and cannulas and shunts often cause serious related medical conditions such as sepsis (Crnich, C.J. & G. Maki, D.G. The Promise of Novel Technology for the Prevention of Intravascular Device- Related Bloodstream Infection. II. Long-Term Devices. Clinical Infectious Diseases 34: 1362-1368 (2002)).

[0248] Other problems include inflammation and wound response. Stents commonly fail or malfunction because of infection or clogging (Tuli, S., Drake, J., Lawless, J., Wigg, M. & Lamberti-Pasculli, M. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J. Neurosurg. 92:31-38 (2000); Noetzel, M.J. & Baker, R.P. Shunt fluid examination: risks and benefits in the evaluation of shunt malfunction and infection. J. Neurosurg. 61 :328-332 (1984)).

[0249] Further, stents are also prone to bacterial contamination that can cause serious infections in the body. A stent is inserted into a natural passage or conduit in the body to prevent or counteract a disease-induced, localized flow constriction. It can also be used to temporarily hold a natural conduit open during surgery. Stents are often heparinized to reduce thrombosis and the effects of bacterial infection. However, despite this precaution, problems associated with clot formation, infection, wound response, and bacterial colonization persist (Garg, N., Garg, R., Gordon, C, Singh, R. & Singh, A. Acute Coronary Syndrome Caused by Coronary Artery Mycotic Aneurysm Due to Late Stent Infection Localized With Radiolabeled Autologous Leukocyte Imaging. Clin. Nucl. Med. 34:753-755 (2009); Dieter, R.S. Coronary artery stent infection. Catheter. Cardio. Inte. 62:281-281 (2004); Dieter, R.S. Coronary artery stent infection. Clin. Cardiol. 23:808-810 (2000); Hearn, A.T., et al. Endovascular stent infection with delayed bacterial challenge. American Journal of Surgery 174:157-159 (1997)).

[0250] Still other medical devices and implants cause problems associated with adhesion and attachment. Artificial heart valves, ventricular assist devices (VAD), and total artificial hearts (TAHs) often cause bacterial infection, endocarditis, and general inflammation (Cribier, A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description. Circulation 106:3006- 3008 (2002), Dismukes, et al. Prosthetic valve endocarditis. Analysis of 38 cases.

Circulation 48:365-377 (1973); Karchmer, A.W., et al. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 98:447-455 (1983); Gristina, A.G., et al. Biomaterial-centered sepsis and the total artificial heart. Microbial adhesion vs tissue integration. JAMA 259:870-874 (1988)).

[0251] Adhesion, attachment, and wound responses often occur when biosensors and bioelectrodes are implanted in the body. The useful life of in vivo biosensors is typically limited due to infection, fouling, and inflammatory response (Wilson, G.S. & Gifford, R. Biosensors for real-time in vivo measurements. Biosens. Bioelectron. 20:2388-2403 (2005); Reichert, W.M., Koschwanez, H.E., Yap, F.Y. & Klitzman, B. In vitro and in vivo characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose sensors. Journal of Biomedical Materials Research Part A 87A:792-807 (2008); Munro, W.A., Thomas, C.L.P., Simpson, I., Shaw, J. & Dodgson, J. Deterioration of pH electrode response due to biofilm formation on the glass membrane. Sensor Actuat B-Chem 37:187- 194 (1996)).

[0252] Also, pacemakers, and bioelectrodes, such as neural electrodes, also face frequent problems of infection, fouling and inflammatory response (S. Karnam, et al.

Mycobacterium phlei, a previously unreported cause of pacemaker infection: Thinking outside the box in cardiac device infections. Cardiology Journal 17 (2010); Sohail, M.R., et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 45: 166-173

(2007) ).

[0253] Endoscopes are difficult to clean and sterilize, and therefore present issues related to the transfer of bacterial, fungal, or viral infection from one patient to another (Beilenhoff, U., et al. ESGE-ESGENA guideline: Cleaning and disinfection in

gastrointestinal endoscopy Update 2008. Endoscopy 40:939-957 (2008); Banerjee, S., et al. Infection control during GI endoscopy. Gastrointest Endosc 67:781-790 (2008)). Further, endotracheal tubes, ventilators, and associated ventilator tubing are typically contaminated with persistent bacterial biofilms, and thus require frequent cleaning and replacement (Afessa, B., et al. Association Between a Silver-Coated Endotracheal Tube and Reduced Mortality in Patients With Ventilator- Associated Pneumonia. Chest 137: 1015-1021 (2010)).

[0254] Additionally, the success of implanted in vivo drug delivery devices is often limited by biofouling processes within the body, which reduces effectiveness of drug delivery (Bhardwaj, U, et al. A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors. J Diabetes Sci Technol 2: 1016-1029

(2008) ; Voskerician, G., et al. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 24: 1959-1967 (2003)).

[0255] SLIPS are used to prevent, reduce, or delay various fluids and other biological materials from wetting surfaces and particles from adhering to surfaces. For example, SLIPS can be incorporated into a microfluidic device, which controls the flow of minute amounts of fluids or gases (e.g., a lab-on-a-chip), for manipulating biological fluids. SLIPS surfaces are useful for preventing, reducing, or delaying inflammatory responses, blood coagulation, antifouling, and adhesion of other products of biological origin in and on devices including wound dressings catheters, stents, and other biomedical devices (e.g., stents, dialysis machines, central veno-venous hemofiltration device, extracorporeal membrane oxygenation equipment, and linking catheters), so that devices can support flow of fluids without permitting wetting of fluids, attachment, or adhesion of particles (see, e.g., FIG. 22A-B). Surfaces of medical instruments and medical devices attract a variety of biological adsorption events and biological responses that are difficult to prevent, reduce, and control. SLIPS can be applied to medical instruments and medical devices to reduce, prevent, or mediate processes associated with protein adsorption, cell attachment, bacterial infection, and inflammatory response.

[0256] For example, SLIPS can be used in wound care, including wounds caused by, e.g., cuts, bruises, punctures, scrapes, tears, and burns. In one embodiment, SLIPS is used to prevent or reduce further damage to damaged skin and to oxygenate the tissue that the SLIPS surface covers. One aspect of this embodiment is burn wound care. Burn wounds become hypoxic because of the layer of damaged tissue. Current burn treatments involve exposing the damaged tissue to high levels of oxygen. This can be accomplished in, e.g., a hyperbaric chamber. However, such wounds must either be covered by a wound dressing, which prevents or reduces the damaged tissue from being exposed to much needed oxygen, or be left exposed and vulnerable to infection. A SLIPS-treated wound dressing that has been infused with oxygenated lubricating fluid can be used to both protect the wound from infection caused by exposure to the environment without adhering to the wound, and provide the wound with oxygen to promote healing.

Medical/ Surgical Instruments

[0257] An important consequence of bacterial contamination and population of surfaces is the infection of surgical instruments, biomedical materials and prosthetics such as catheters (Costerton, J.W., et al. Bacterial biofilms in nature and disease. Ann. Rev.

Microbiol. 41 :435-464 (1987); Gristina, A.G., Dobbins, J.J., Giammara, B., Lewis, J.C. & DeVries, W.C. Biomaterial-centered sepsis and the total artificial heart. Microbial adhesion vs tissue integration. JAMA 259:870-874 (1988)). Bloodstream infection caused by surgical instrument-related bacterial contamination is a frequent and serious complication associated with procedures involving catheters and implants (Costerton et al, 1987;

Gristina, 1988). Such infections trigger an immune response in the body, which can lead to inflammation of the infection site.

[0258] Surgical instruments and intravascular devices (IVD) such as catheters have many potential sources for infection. The adherence of microorganisms to catheter surfaces is among the most important characteristics associated with the pathogenesis of infection caused by catheter use. Even a single bacterium cell that successfully adheres to surface can develop into a robust and infectious bacterial film and cause disease. Therefore an effective strategy for prevention or reduction of bacterial adhesion is needed.

Wound Dressings [0259] In another embodiment, SLIPS is incorporated into a wound dressing. SLIPS surfaces do not permit adhesion of proteins or cells when contacted with biological fluids. Moreover, perfluorocarbons have a high solubility for oxygen (Clark, Leland C; Gollan, F. Science 152(3720): 1755-56 (1966); Shaffer, T.H. et al, Pulmonol. 14: 102-109 (1992)). Thus, a wound dressing that incorporates SLIPS with, e.g., a perfluorocarbon substrate, provides a breathable surface that prevents adhesion of proteins or cells to promote faster wound healing (see, e.g., FIG. 23).

EXAMPLES

[0260] The following examples are presented for the purpose of illustration only and are not intended to be limiting.

Example 1

[0261] A set of SLIPS was fabricated to repel fluids spanning a broad range of surface tensions. To generate roughness, two types of porous solids were tested. The porous solids were periodically ordered and random: (i) arrays of nanoposts functionalized with a low- surface-energy polyfluoroalkyl silane, and (ii) a random network of Teflon nano fibres distributed throughout the bulk substrate (FIG. 17). Low-surface-tension perfluorinated liquids (e.g. FC-70, 7B = 17.1 mN/m; or Dupont^™ Krytox^® oils) that are non- volatile and immiscible with both aqueous and hydrocarbon phases and therefore able to form a stable, slippery interface with substrates (i.e.,

> 0 and E₂ > 0) for a variety of polar and non- polar liquids including water, acids and bases, alkanes, alcohols, and ketones (FIG. 15 and FIG. 17) were chosen for the lubricating fluid. The SLIPS were generated through liquid infiltration into the porous materials, which resulted in a homogeneous and nearly molecularly smooth surface with a roughness of ~1 nm.

[0262] Each of these SLIPS exhibited extreme fluid repellency as signified by very low contact angle hysteresis (CAH, ΑΘ < 2.5°, FIG. 17 and FIG. 18A) and by very low sliding angles (a < 5° for droplet volume > 2 μί) against fluids of surface tension ranging from -17.2 ±0.5 mN/m (i.e., n-pentane) to 72.3 ±0.3 mN/m (i.e., water). CAH, the difference between the advancing and receding contact angles of a moving droplet, and sliding angle, the surface tilt required for droplet motion, directly characterize resistance to mobility; the low values therefore confirm a lack of pinning, consistent with a nearly defect-free surface. Based on the measured CAH and droplet volume (~4.5 μί), the estimated fluid retention force on SLIPS was 0.83±0.22 μΝ, n = 6. This performance was nearly an order of magnitude better than the state-of-the-art lotus-leaf-inspired omniphobic surfaces, whose fluid retention forces are of the order of 5 μΝ for low-surface-tension fluids (i.e., 7A < 25 mN/m) at similar fluid volumes. Moreover, the f uid-repellency of SLIPS was insensitive to texture geometry (FIG. 18A), provided that the lubricating layer covered the textures. Additionally, unlike lotus-based omniphobic surfaces where CAH depends on fluid surface tension and increases dramatically upon decrease of surface tension (FIG. 18A), such a dependence was absent for SLIPS due to the chemical homogeneity and physical smoothness of the fluid-fluid interface.

Example 2

[0263] The disclosed surfaces provide an ultra-smooth surface capable of preventing, reducing, or delaying surface wetting of fluids that come into contact with SLIPS.

[0264] An experiment was conducted in which the difference in surface adhesion of blood on PDMS was compared to that of an oil-infiltrated PTFE surface. 0.75 mL of fresh whole blood from a human subject was used, without the addition of heparin. The whole blood was pipetted onto four surfaces, one consisted of microstructured PTFE (Teflon; 1 μιη pore size) impregnated with perfluorinated oil (FC-70), the second consisted of untreated microstructured PTFE which served as the control, the third surface was untreated glass, and the fourth surface was untreated PDMS. FIG. 11 shows sequential images of the blood sample being added to PDMS (FIG. 11 A) and microstructured PTFE impregnated with perfluorinated oil (FIG. 11B). The surfaces made of PDMS (FIG. 11 A), microstructured PTFE (FIG. 12D), and glass (FIG. 12A), all allowed the blood sample to wet the surfaces and rapidly coagulate and adhere to these materials. The SLIPS that consisted of microstructured PTFE impregnated with perfluorinated oil (FIG. 11B) caused the blood sample to immediately bead into droplets and slide along SLIPS.

[0265] Referring to FIG. 13, subsequent analysis of these surfaces using optical (FIGS. 12(A)(i), 12(B)(i)) and scanning (FIGS. 12(A)(ii), 12(B)(ii)) electron microscopy, to show that while blood species such as cells, platelets, and proteins are visibly deposited on the untreated glass, PDMS, and PTFE control surfaces, there is nothing visible on the oil- infiltrated PTFE material. Thus, this 'fluid-like' surface appears to be extremely effective at preventing or reducing adhesion of platelets and fibrin clot formation when in contact with fresh unheparinized human blood.

Example 3 [0266] Experiments using 2 μιη polystyrene particles showed that force of adhesion to slippery surfaces was extremely low, such that the particles were easily dragged by a fluid/air boundary interface across SLIPS, and concentrated into the center of a drying droplet instead of leaving a 'coffee ring' deposition.

Example 4

[0267] Experiments were conducted to determine whether fluid from SLIPS leach into the surrounding biological fluid. A nanostructured post array surface (2 μιη tall posts, 300 nm diameter, 0.9 μιη spacing) with infiltrated perfluorinated oil (Fluorinert FC-70) was integrated into a microfluidic system. Deionized water flowed into the channel at a rate of 12 mL/min (i.e., 720 mL/hr) for 5 minutes. It was found that the perfluorinated oil remained intact on the nanostructured surface. The slipperiness of the surface was examined by putting a droplet of decane on the surface. If decane applied to the surface maintains its mobility on the surface, then the lubricants remain attached on the structured surface. However, if decane remains pinned on the surface, the lubricant layer has not been maintained. Leaching can also be monitored by extracting fluid that has passed over SLIPS into a fluorinated solvent followed by followed by chromatography and mass spectrometry and 19F-NMR.

[0268] Defining maximum leaching of the infiltrated fluid as the ratio between the total amounts of the perfluorinated oil infiltrated the surface and the volume of water processed in the microfluidic system, the maximum leaching was < 0.2%. Because perfluorocarbons are already approved by the Food and Drug Administration as blood substitutes, leaching of this amount of oil is expected to be harmless. The effective viscosity can be increased to reduce the amount of leaching while maintaining the 'fluid- like' surface that resists blood clot attachment.

Example 5

[0269] The slippery surfaces produced in accordance with the present methods showed excellent prevention of attachment and/or facilitation of low-force detachment of mature bacterial biofilm incubated on the surface. Specifically, this capability is demonstrated for Pseudomonas aeruginosa, a human opportunistic pathogen, and one of the most common nosocomial infections in the lining of catheters and the lungs of cystic fibrosis patients.

[0270] The surface was fabricated by wicking 100 of various commercial fluids satisfying criteria for a lubricating fluid into 30 mm round Teflon filter membranes with 0.2 μιη pore size, which were then mounted onto standard polystyrene Petri dishes. Atop the slippery surfaces, 2 mL tryptone broth puddles for 24 hours that were inoculated at 1% with Pseudomonas aeruginosa preculture were deposited and statically incubated. The bacteria formed a mature biofilm during this timeframe, and the slime-like matrix binding the constituent cells tends to gel the puddle.

[0271] The slippery surfaces produced in accordance with the present disclosure caused the slimy mass to readily slide off when tilted, as shown in FIG. 19, even at tilt angles below 10°. The effective slide-off removal of biofilm slime on the slippery surfaces produced in accordance with the present disclosure contrasts to the adhesion and pinning of the basal layer of slime on unfilled 0.2 μιη Teflon filters (left of FIG. 19) as well as on fluorosilanized super hydrophobic silicon micro/nanostructure arrays (right of FIG. 19), whose fluid repellency properties failed during the conditioning film and slime production of biofilm.

[0272] In addition to the visually apparent slide -off of biofilm slime, the slippery surfaces produced in accordance with the present disclosure showed nearly no adherent bacteria on the surfaces. Any remaining adherent bacteria was fixed with 5%

glutaraldehyde in phosphate buffered saline, permeabilized, and marked with a nucleic acid stain for fluorescent cell imaging. Fluorescent microscopy revealed a lack of biofilm structures or any microcolonies remaining on the slippery surfaces produced in accordance with the present methods following 24 hour incubation, as shown in FIG. 20. In contrast, significant remaining biomass was left on the unfilled 0.2 μιη Teflon filters as well as on three different fluorosilanized super hydrophobic silicon micro/nanostructure arrays (submicron posts and 10 μιη and 5 μιη "brick wall" patterns).

Example 6

[0273] The slippery surfaces produced in accordance with the present disclosure can be designed to be nontoxic by appropriate selection of the lubricating fluid, enabling applications with medical and environmental requirements. Among the commercial fluids already available, eight products that can satisfy the requirements for a lubricating fluid were screened and five candidates were identified for low toxicity (see FIG. 21). The toxicity screening assay was based on adding 1% and 0.01% of each commercial product to 10 mL aliquots of tryptone broth, which were inoculated with 1% initial seeding concentration of Pseudomonas aeruginosa (PA- 14) preculture and incubated at 37° C overnight in an orbital shaker. The shaken culture was serially diluted, plated, and incubated for colony forming unit (CFU) quantification. Significantly reduced CFU at the 1% concentration versus 0.01% concentration of FC70, Krytox 100, and Perfluorodecalin indicated an inhibitive effect and screened out these products for toxicity-sensitive applications. The remaining five products— Krytox 103/104/105 and FG40/45— are viable candidates for slippery fluid surfaces designed to minimize bacterial adhesion as well as toxicity.

Example 7

[0274] Teflon and silicon wafer SLIPS surfaces prepared in accordance with the present disclosure were shown to prevent bacterial attachment.

SLIPS fabrication

[0275] To prepare SLIPS, lubricating liquid (Dupont^™ Krytox^® 100 and 103) was added onto the porous solids, Teflon membranes with average pore sizes of > 200 nm and about 60 - 80 μιη thick (Sterlitech Corporation, WA, USA), to form an over-coated layer. The fluid spread spontaneously onto the whole substrate through capillary wicking.

Silicon Microstructure Array Fabrication

[0276] Superhydrophobic microstructure arrays were fabricated on a 4" silicon wafer by the Bosch process (M. Sugawara, e.a., Plasma Etching: Fundamentals and Applications . Series on semiconductor science and technology. Vol. 7. 1998, New York: Oxford

University Press). The microstructures consisted of four types of geometries: d = 500 nm HAR nanoposts, 2 μιη pitch; d = 1 μιη HAR microposts, p = 3 μιη; 5 μιη T-shaped microposts; and 10 μιη T-shaped microposts. The wafer was rinsed with EtOH, oxygen plasma treated for 30 seconds, and was rendered hydrophobic by putting the sample in a vacuum desiccator overnight with a glass vial containing 0.2 mL heptadecafiuoro-1,1,2,2- tetrahydrodecyltrichlorosilane (Gelest Inc).

Bacterial Preparation and Growth

[0277] Bacterial strains Pseudomonas aeruginosa PA14, Staphylococcus aureus SCOl, and Escherichia coli ZK2686 were each grown in LB medium (EMD LB Broth Miller) overnight at 37°C in loosely capped tubes on an orbital shaker to the stationary phase. This LB preculture was then seeded at 1% concentration in one of the following: TB growth medium (BD Bacto Tryptone) for P. aeruginosa; TSB medium supplemented with 0.5% glucose and 3% NaCl for S. aureus; or M9 medium for E. coli. These cultures were incubated on the bench at room temperature during experiments.

Flow Cell Setup [0278] A Tygon tube of inner diameter 1/8" was mounted in a peristaltic pump (Cole Parmer) and connected via hose barb fittings (World Precision Instruments) to a dual- chamber 3D-printed flow cell (chamber dimensions 1 = 10 cm, w = 1 cm, h = 1 mm).

[0279] The tubing was configured to allow flow in series through the two chambers. The bottom surface and sidewalls of each chamber were lined with press-fit porous Teflon membrane; one was infused with Krytox 103 to create a SLIPS and the other was left untreated as a control. Bacterial culture was pumped into each tube until the loop was full and trapped air had been eliminated though a bubble escape, after which the pump was operated at 10 mL/min.

Toxicity Screening

[0280] Shaken cultures of 1% P. aeruginosa in TB were grown in triplicate with 1% by volume of the following reagents: Krytox 100, Krytox 103, Perfluorodecalin, FC70, bleach, and 0.1% of AgN0₃ and glutaraldehyde. Background samples containing only media and reagents were also prepared, as well as control cultures without added reagents. Samples were incubated in an orbital shaker at 37 °C at 200 rpm. Optical density measurements at 550 nm were taken at 3, 6, 9, and 30 hours on a Perkin Elmer Lambda 40 UV-Vis spectrometer. Optical densities were normalized by subtracting backgrounds, i.e., the reagents in TB only.

Imaging and Analysis

[0281] For fluorescence imaging of attached bacterial cells, the PTFE substrates mounted in the flow cell were removed, gently rinsed in phosphate buffered saline (PBS) (lx) (Lonza Biowhittaker), and the adherent bacteria were fixed by 5% glutaraldehyde solution for at least 1 hour. 0.01% Triton XI 00 in PBS (PBST) was used to permeabilized the bacteria membranes over 15 minutes, after which the cells were stained with 0.5 μΜ SYTOX green nucleic acid stain (Invitrogen) in PBST for 30 minutes. Imaging was performed on a Leica DMX microscope.

[0282] To analyze the fluorescence intensity of the micrographs from the control and SLIPS flow cell substrates, the average intensity image of each sample's micrograph set was generated in ImageJ and the average [(R+G+B)/3] pixel value and standard deviation were computed for each average intensity image.

Biofilm quantification by crystal violet staining [0283] PTFE substrates were carefully sectioned with a scalpel into 3 x 3 cm segments, removed from the flow cell, gently rinsed in PBS, and stained by 0.1% crystal violet for 20 minutes. The stained samples were rinsed in a DIW bath and the bound crystal violet on each was eluted into 4 mL of 100% EtOH. Absorbance values at 590 nm were measured on a Perkin Elmer Lambda 40 UV-Vis spectrometer.

Prevention of Biofilm Attachment/ Formation

[0284] In a simple test scheme, Pseudomonas aeruginosa TB culture was deposited in puddles that were statically grown upon three surface typologies, two of which are shown in FIG. 36A. A porous PTFE membrane (0.2 μιη pore size) served as a flat, conventional low-adhesive control surface; a fluorosilanized patterned silicon wafer (not shown) featuring four different high-aspect-ratio micropost arrays presented superhydrophobicity, the capacity to repel and roll off water; and a PTFE membrane infused with Krytox-103 provided a SLIPS liquid slippery surface. After 48 hours of room temperature growth, the viable cell concentration of the imposed bacterial cultures on both surfaces was on the order of 10⁸ mL^"1. The bacteria were fixed and stained, and the fluorescence micrographs of resulting growth are shown in FIG. 36A, insets. While robust and uniform biofilm coverage was observed on both flat PTFE and superhydrophobic silicon (not shown), only sparse and isolated cells were seen on the SLIPS (see, e.g., FIG. 36C).

[0285] The test surfaces were manually tilted to compare the adhesion of the macroscopic biofilm slime. Biofilm grown on the control and superhydrophobic substrates showed complete wetting of the surface and left a film of slime on the PTFE as it was tilted. In contrast, biofilm on the SLIPS substrate slid readily without leaving any slime film or other visible residue behind. Biofilm growing in contact with the bare polystyrene Petri dish at the edge of the SLIPS remained pinned. However, it was not attached to the SLIPS substrate underneath: when part of the pinned puddle was disconnected from the edge and manipulated toward the center, it became fully mobile.

[0286] The contact line pinning characteristics of the surfaces (i.e., SLIPS and porous Teflon) were characterized by monitoring the evaporation dynamics of the bacterial culture droplets as well as the stains that remained on the surfaces upon drying. In the absence of pinning, the droplet should follow a nearly constant contact angle mode of evaporation without the formation of a coffee ring stain. [0287] These hypotheses were consistent with observations of the bacteria droplet' s evaporation on SLIPS. The absence of the coffee ring formation also indicated that the adhesion of the bacteria on the SLIPS was small compared to the forces imparted by the meniscus of the droplet, and it was demonstrated that the dried biofilm was easily removed from SLIPS by adhesive tape. In contrast, an evaporating droplet on the porous Teflon was strongly pinned, leading to a constant contact area mode of evaporation which also resulted in the formation of an irremovable coffee ring. These demonstrations of biofilm non- attachment to SLIPS and resisting 3.5 x 10⁸ mL^"1 bacterial liquid were consistent with both macroscopic and microscopic quantification data obtained herein.

[0288] Most submerged biofilm formation occurs under various flow conditions, e.g., in plumbing, ship hulls, catheters, and the like. Accordingly, biofilm attachment was studied on test surfaces lining a dual 3D-printed flow cell, through which the bacterial culture was continuously circulated by a peristaltic pump. Under flow conditions of 10 mL/min and ~1 cm/s, both a control PTFE and SLIPS surface were exposed in parallel to PA14 bacterial culture for 24 hour, 48 hour, and 7-day (168 hour) periods. Photographs of the two substrates following 48 hour growth show a yellowish, slimy control substrate and a visually uncontaminated SLIPS (FIG. 37A-B).

[0289] When tilted, biofilm slime spread on the control substrate but slid off the SLIPS. The attached biofilm was also stained by crystal violet for both visual inspection and quantitative biomass comparison by optical density. This macroscopic assay showed a dramatic difference between the substrates, as shown in (FIG. 37A-B). Indeed, crystal violet absorbance, proportional to the attached biomass, showed a 99.6% average reduction in biofilm on SLIPS as compared to control PTFE following the 7-day bacterial growth (FIG. 37C). By comparison, PEGylated titanium surfaces have been reported to reduce biofilm attachment by 86% after 5 hours of growth. The 48 hour growth of P. aeruginosa on Ti-coated glass slides was found to differ by < 19%> from PTFE, indicating similar long- term biofilm attachment on these two controls and thus a similar starting point for attachment reduction. Even if PEG desorption is assumed to not occur due to recent advances in multi-tether attachment, and even if no chemical masking occurred after 7 days submerged in bacterial culture, the 14% of remaining biofilm would be ~35 times more than on the SLIPS substrate. [0290] It is worth noting that the flow velocity in this experiment of ~1 cm/s is a conservatively gentle condition. In other environments where biofilms form, e.g., a ½-inch building water pipe or a ship hull at 20 knot cruise speed, typical flow velocities can be on the order of 1 m/s and 10 m/s respectively, with proportionately higher shear forces that would support biofilm removal from a SLIPS substrate. In biological and biomedical systems such as indwelling catheters, urinary tracts, and the human vascular system, flow velocities are also frequently more aggressive, on the order of 10-100 cm/s.

[0291] To characterize biofilm attachment to PTFE and SLIPS substrates on the microscale, multiple sample areas following 24 hour, 48 hour, and 7-day flow condition growths were fluorescently imaged. The results were analogous to those achieved in the initial static growth experiment. Biofilm on the control surface appeared characteristically dense, three-dimensional, and uniform (FIG. 38A-B). On the SLIPS, only sparse, isolated single cells or microcolonies were observed (FIG. 38C-D), and these appeared to be unattached, i.e., drifting with convective currents in the ambient fluid. This observation further supports that a liquid surface provides very low adhesion to the individual bacteria or micro-colonies. The average fluorescence intensities of 20 representative fields of view per substrate were computed as numeric pixel averages [(R+G+B)/3]. While not fully capturing intensity from out-of-focus biofilm structure on the control surface, the control values may be considered a lower bound; thus there is at least a 98% average intensity reduction in the fluorescence signal from PTFE to SLIPS, similar to the global

quantification by crystal violet.

[0292] To confirm that the dramatic biofilm attachment inhibition on SLIPS substrates was not a result of cytotoxicity of the SLIPS liquids, four of the liquids were screened for effects on bacterial growth. These included the Krytox 103 used for SLIPS fabrication in this study, as well as FC70, Krytox 100, and perfluorodecalin (traditionally used as a blood- substitute). The growth curves of P. aeruginosa were measured following growth in shaken TB cultures— thereby assuring uniform exposure— with 1% and 0.1% concentrations of each SLIPS liquid. As seen in FUG, 38E, optical densities showed statistically

indistinguishable bacterial growth at 3, 6, 9, and 30 hours for all tested SLIPS liquids and concentrations as compared to the control culture. Equivalent concentrations of three negative controls—silver nitrate (a common antiseptic compound and representative of silver impregnated surfaces), bleach, and glutaraldehyde (commonly used for clinical tool sterilization)— were also tested. As expected, all three exhibited massive toxicity within these timeframes, in contrast to the null effect of the SLIPS liquids.

[0293] The attachment of two other clinically important, pathogenic, biofilm-forming species, Staphylococcus aureus (SCOl) and Escherichia coli (ZK2686) was studied for 48 hours under identical flow conditions. SLIPS performance comparable to that of

Pseudomonas aeruginosa was observed. As shown in FIG. 39A-B, S. aureus attachment was reduced by 97.2% and E. coli by 96% versus PTFE. While neither of these species formed as robust biofilms as did P. aeruginosa, their final attachment to SLIPS was similarly low based on crystal violet absorbance. Visualized by fluorescence in FIG. 39D- F, dense uniform coverage and sparse, isolated cells respectively attached to the control surface and SLIPS. This indicated that SLIPS 's anti-bio film function was nonspecific and spanned phylogenetically diverse pathogenic bacteria.

[0294] Thus, it is apparent that the bacteria were presented with a smooth liquid "surface," and as such, were unable to anchor to the surface via pili and other cellular mechanisms as would be possible on a solid surface. The SLIPS lubricating liquid was also immiscible with the aqueous bacterial medium (Liquid A), and the surface tension at the interface (on the order of 50 mN/m) was likely difficult for bacteria to penetrate, even with bacterial surfactant production. Indeed, bacteria embedding within the SLIPS was not observe, which indicates that bacteria could not swim through the interface. Without access to the solid material beneath the lubricating liquid, bacteria were unable to attach, and remained subject to ambient flow and thus subject to passive removal.

Example 8

[0295] SLIPS can be used to coat medical devices, including tubing, to prevent, reduce, or delay blood clot formation and cell adhesion. FIG. 31 A shows the experimental setup in included a 24" loop of SLIPS tubing (ePTFE+FC70) and a 24" loop of standard silicone tubing (0.250"ID) as a control. The preformed ePTFE tube was saturated with PFC FC70 oil, and encased in a silicone tube to help prevent oil loss and evaporation. Both the ePTFE SLIPS tube and the silicone tube control were filled with 12 mL of the diluted blood. A 24" preformed ePTFE tube was saturated with PFC FC-70, and encased in a silicone tube where it interfaced with a peristaltic pump and Tygon tubing in other regions to create an FC-70 reservoir. Fresh whole human blood (12 mL, diluted 1 : 1 with saline) free of anticoagulant was pumped through both sets of tubing at 3,000 mL/hr. After 20 minutes, there was no sign of clotting within the entire length of tubing (FIG. 30 and FIG. 31B). There was some staining (surface adsorption) in the region of the peristaltic pump roller contact (FIG. 30B), suggesting potential mechanical damage and infiltration of blood into the ePTFE at this site. After 30 min of flow there was no sign of clotting and minimal surface adhesion within the entire length of SLIPS tubing (FIG. 31C). In the silicone tubing there were signs of clotting and significant surface adhesion within the tube.

[0296] As will be apparent to one of ordinary skill in the art from a reading of this disclosure, aspects of the present disclosure can be embodied in forms other than those specifically disclosed above. The particular embodiments described above are, therefore, to be considered as illustrative and not restrictive. Those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation, numerous equivalents to the specific embodiments described herein. The scope of the invention is as set forth in the appended claims and equivalents thereof, rather than being limited to the examples contained in the foregoing description.

[0297] What is claimed is:

Claims

1. An article for repelling a biological material, comprising: a lubricating fluid layer, wherein the lubricating fluid is immiscible with a biological material, the lubricating layer forming an ultra-smooth surface over a roughened solid substrate; wherein the lubricating fluid adheres to the substrate and the substrate is

preferentially wetted by the lubricating fluid, the solid substrate and lubricating fluid forming a slippery surface configured and arranged to contact a biological material.

2. The article of claim 1 , wherein the article satisfies the following condition y_Bxcos6>Bx - 7AXCOS( AX > 0 (el) wherein ^AX is the interfacial energies of the biological material with a surrounding medium; wherein y_Bx is the interfacial energies of the lubricating fluid with the surrounding medium; wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium; and wherein 6½χ is the equilibrium contact angle of the liquid of the lubricating fluid on a flat solid surface immersed under the surrounding medium.

3. The article of claim 1 , wherein the article satisfies the following two conditions when the article is exposed to Medium X, where X is air/gas/water/immiscible biological material: ?(yBxCOs6>Bx - 7AXCOS6>AX) - 7AB > 0 (e2) ?(yBxCOs6>Bx - 7AXCOS6>AX) + 7AX - 7BX > 0 (e3) wherein ^AX is the interfacial energies of the biological material with a surrounding medium; wherein }¾x is the interfacial energies of the lubricating fluid with the surrounding medium; wherein }ΆΒ is the interfacial energies of the biological material and the lubricating fluid interface; wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium; wherein 6½χ is the equilibrium contact angle of the lubricating fluid on a flat solid surface immersed under the surrounding medium wherein R is a roughness factor of the roughened surface.

4. The article of claim 1 , wherein the substrate is a roughened surface comprising a porous material.

5. The article of claim 1 , wherein the solid substrate is electrically conductive, non- conductive, magnetic, non-magnetic, elastic, non-elastic, light sensitive, or not light sensitive.

6. The article of claim 4, wherein porous material includes a solid substrate having a plurality of holes, three-dimensionally interconnected network of holes and one or more materials, or random array of fibrous materials.

7. The article of claim 1 , wherein microparticles or nanoparticles are applied to a flat substrate to form a roughened, porous substrate.

8. The article of claim 1 , wherein the substrate is silanized.

9. The article of claim 1 , wherein the lubricating fluid infiltrates the substrate by capillary action.

10. The article of claim 7, wherein the substrate is roughened using photolithography, projection lithography, e-beam writing or lithography, depositing nanowire arrays, growing nanostructures on the surface of a substrate, soft lithography, replica molding, solution deposition, solution polymerization, electropolymerization, electrospinning, electroplating, vapor deposition, layered deposition, rotary jet spinning of polymer nanofibers, contact printing, etching, transfer patterning, microimprinting, self-assembly, boehmite (γ-ΑΙΟ(ΟΗ)) formation, spray coated, and combinations thereof.

11. The article of claim 1 , wherein the substrate consists of a fluoropolymer.

12. The article of claim 1, wherein substrate is selected from the group consisting of a polydimethylsiloxane, polypropylene, polytetrafluoroethylene, and combinations thereof.

13. The article of claim 12, wherein the lubricating fluid is selected from the group consisting of liquid silicone elastomers, vegetable or mineral oil, liquid hydrocarbons, and combinations thereof.

14. The article of claims 12 or 13, wherein the biological material is selected from the group consisting of a simple aqueous fluid, a complex aqueous fluid, a solidified fluid, and combinations thereof.

15. The article of claims 1, wherein the biological material does not adhere to the surface.

16. The article of claim 1, wherein the substrate is selected from the group consisting of fluoro-silanized metals, fluoro-silanized natural polymers, fluoro-silanized synthetic polymers, and combinations thereof.

17. The article of claim 16, wherein the lubricating fluid is a perfluorinated fluid.

18. The article of claims 16 or 17, wherein biological material a non-perfluorinated fluid.

19. The article of claim 1, wherein the biological material is selected from the group consisting of whole blood, plasma, serum, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, and combinations thereof.

20. The article of claim 1, wherein the biological material is a solution or suspension containing bacteria selected from the group consisting of Actinobacillus {e.g. , Actinobacillus actinomycetemcomitans), Acinetobacter {e.g., Acinetobacter baumannii), Aeromonas, Bordetella (e.g., Bordetella pertussis, Bordetella bronchiseptica, and Bordetella

parapertussis), Brevibacillus, Brucella, Bacteroides (e.g., Bacteroides fragilis),

Burkholderia (e.g., Burkholderia cepacia and Burkholderia pseudomallei), Borelia (e.g., Borelia burgdorfen), Bacillus (e.g., Bacillus anthracis and Bacillus subtilis), Campylobacter (e.g., Campylobacter jejuni), Capnocytophaga, Cardiobacterium (e.g., Cardiobacterium hominis), Citrobacter, Clostridium (e.g. , Clostridium tetani or Clostridium difficile), Chlamydia (e.g., Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psiffaci), Eikenella (e.g., Eikenella corrodens), Enterobacter, Escherichia (e.g., Escherichia coli), Francisella (e.g., Francisella tularensis), Fusobacterium, Flavobacterium, Haemophilus (e.g., Haemophilus ducreyi or Haemophilus influenzae), Helicobacter (e.g., Helicobacter pylori), Kingella (e.g., Kingella kingae), Klebsiella (e.g., Klebsiella pneumoniae), Legionella (e.g., Legionella pneumophila), Listeria (e.g., Listeria monocytogenes), Leptospirae, Moraxella (e.g., Moraxella catarrhalis), Morganella, Mycoplasma (e.g. , Mycoplasma hominis and Mycoplasma pneumoniae), Mycobacterium (e.g. , Mycobacterium tuberculosis or Mycobacterium leprae), Neisseria (e.g., Neisseria gonorrhoeae or Neisseria

meningitidis), Pasteurella (e.g., Pasteurella multocida), Proteus (e.g., Proteus vulgaris and Proteus mirablis), Prevotella, Plesiomonas (e.g., Plesiomonas shigelloides), Pseudomonas (e.g., Pseudomonas aeruginosa), Providencia, Rickettsia (e.g., Rickettsia rickettsii and Rickettsia typhi), Stenotrophomonas (e.g. , Stenotrophomonas maltophila), Staphylococcus (e.g., Staphylococcus aureus and Staphylococcus epidermidis), Streptococcus (e.g.,

Streptococcus viridans, Streptococcus pyogenes (group A), Streptococcus agalactiae (group B), Streptococcus bovis, and Streptococcus pneumoniae), Streptomyces (e.g., Streptomyces hygroscopicus), Salmonella (e.g., Salmonella enteriditis, Salmonella typhi, and Salmonella typhimurium), Serratia (e.g., Serratia marcescens), Shigella, Spirillum (e.g., Spirillum minus), Treponema (e.g., Treponema pallidum), Veillonella, Vibrio (e.g., Vibrio cholerae, Vibrio parahaemolyticus, and Vibrio vulnificus), Yersinia (e.g., Yersinia enter ocolitica, Yersinia pestis, and Yersinia pseudotuberculosis), Xanthomonas (e.g., Xanthomonas maltophilia) and combinations thereof.

21. The article of claim 1, wherein the biological material is a solution or suspension containing fungi selected from the group consisting of a member of the genus Aspergillus (e.g., Aspergillus flavus, Aspergillus fumigatus, Aspergillus glaucus, Aspergillus nidulans, Aspergillus niger, and Aspergillus terreus), Blastomyces dermatitidis, Candida (e.g. , Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, and Candida guillermondii), Coccidioides immitis, Cryptococcus (e.g., Cryptococcus neoformans, Cryptococcus albidus, and Cryptococcus laurentii), Histoplasma capsulatum var. capsulatum, Histoplasma capsulatum var. duboisii, Paracoccidioides brasiliensis, Sporothrix schenckii, Absidia corymbifera; Rhizomucor pusillus, Rhizopus arrhizous, and combinations thereof.

22. The article of claim 1, wherein the biological material is a solution or suspension containing viruses selected from the group consisting of cytomegalovirus (CMV), dengue, Epstein-Barr, Hantavirus, human T-cell lymphotropic virus (HTLV I/II), Parvovirus, hepatitides (e.g., hepatitis A, hepatitis B, and hepatitis C), human papillomavirus (HPV), human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), respiratory syncytial virus (RSV), Varicella zoster, West Nile, herpes, polio, smallpox, yellow fever, rhinovirus, coronavirus, Orthomyxoviridae (influenza viruses) (e.g.,

Influenzavirus A, Influenzavirus B, Influenzavirus C, Isavirus and Thogotovirus), and combinations thereof.

23. The article of claim 1, wherein the biological material is a solution or suspension containing particles selected from the group consisting of normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, stem cells, and infected cells, microorganisms, viruses, virus-like particles, bacteria, bacteriophages, proteins, cellular components, cell organelles, cell fragments, cell membranes, cell membrane fragments, viruses, virus-like particles, bacteriophage, cytosolic proteins, secreted proteins, signaling molecules, embedded proteins, nucleic acid/protein complexes, nucleic acid precipitants, chromosomes, nuclei, mitochondria, chloroplasts, flagella, biominerals, protein complexes, and minicells.

24. The article of claim 1, wherein the biological material is a natural or synthetic solution used in medicines, intravenous solutions, pharmaceutical manufacturing, or medication delivery systems.

25. The article of claim 1, wherein the lubricating fluid is capable of self-healing by wicking back to the damaged region of the substrate after physical damage of the substrate to form the ultra-smooth surface.

26. The article of claim 25, wherein a recovery time for self-healing occurs in less than 50 ms, 60 ms, 70 ms, 80 ms, 90 ms, 100 ms, 110 ms, 120 ms, 130 ms, 140 ms, 150 ms, 160 ms, 170 ms, 180 ms, 190 ms, 200 ms, 210 ms, 220 ms, 230 ms, 240 ms, 250 ms, 1 second, 5 seconds 10 seconds, 30 seconds, 60 seconds, 90 seconds, or 120 seconds or more.

27. The article of claim 1, wherein the substrate has a plurality of holes, three- dimensionally interconnected network of holes and one or more materials, or random array of fibrous materials.

28. The article of claim 1, wherein the substrate consists of a material selected from the group consisting of polymers, metals, sapphire, glass, diamond, graphite, black carbon, or ceramics.

29. The article of claim 1, wherein the substrate is a hemocompatible material.

30. The article of claim 1, wherein the substrate is a polymer selected from the group consisting of polytetrafluoroethylene (PTFE), polyvinylfluoride, polyvinylidene fluoride, and fluorinated ethylene propylene.

31. The article of claim 1 , wherein the lubricating fluid has a density greater than the density of the biological material.

32. The article of claim 1, wherein the lubricating fluid has a density greater than lubricating fluid has a density that is more than 1.0 g/cm³, 1.6 g/cm³, or 1.9 g/cm³.

33. The article of claim 1, wherein the lubricating fluid comprises a fluid selected from the group consisting of tertiary perfluoroalkylamines,perfluorotri-n-butylamine,

perfluoroalkylsulfides, perf uoroalkylsulfoxides, perf uoroalkylethers, perfluorocycloethers, perfluoropolyethers, perfluoroalkylphosphines, perfluoroalkylphosphineoxides, and combinations thereof.

34. The article of claim 1, wherein the lubricating fluid prevents, reduces, or delays adhesion, coagulation, or clot formation of biological materials.

35. An article having a repellant surface, the article comprising:

a solid substrate comprising a roughened surface; and a lubricating fluid wetting and adhering to the roughened surface to form a stabilized liquid overlayer, wherein the liquid covers the roughened surface, wherein the roughened surface and the lubricating liquid have an affinity for each other such that the lubricating liquid is substantially immobilized on the substrate.

36. A device capable of repelling a biological material, comprising: a lubricating fluid layer, wherein the lubricating fluid is immiscible with the biological material, the lubricating layer forming an ultra-smooth surface; and a solid substrate, wherein the lubricating fluid adheres to the substrate and the substrate is preferentially wetted by the lubricating fluid, the solid substrate and lubricating fluid forming a slippery surface configured and arranged to contact a biological material, wherein the device satisfies the following condition y_Bxcos6>Bx - 7AXCOS( AX > 0 (el) wherein ^AX is the interfacial energies of the biological material with a surrounding medium; wherein y_Bx is the interfacial energies of the lubricating fluid with the surrounding medium; wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium; and wherein 6½χ is the equilibrium contact angle of the liquid of the lubricating fluid on a flat solid surface immersed under the surrounding medium.

37. The device of claim 36, wherein the device further satisfies the following two conditions when the article is exposed to Medium X, where X is air/gas/water/immiscible biological material: ?(yBxCOs6>Bx - 7AXCOS6>AX) - 7AB > 0 (e2) ?(yBxCOs6>Bx - 7AXCOS6>AX) + 7AX - 7BX > 0 (e3) wherein ^AX is the interfacial energies of the biological material with a surrounding medium; wherein }¾x is the interfacial energies of the lubricating fluid with the surrounding medium; wherein }ΆΒ is the interfacial energies of the biological material and the lubricating fluid interface; wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium; wherein 6½χ is the equilibrium contact angle of the lubricating fluid on a flat solid surface immersed under the surrounding medium wherein the solid substrate is a roughened surface, and R is a roughness factor of the roughened surface.

38. The device of claim 36, wherein the solid substrate is silanized.

39. The device of claim 36, wherein the solid substrate is electrically conductive, non- conductive, magnetic, non-magnetic, elastic, non-elastic, light sensitive, or not light sensitive.

40. A device selected from the group of cannula, connector, catheter, needle, capillary tube, tubing, syringe and combinations thereof, wherein at least a portion of the device comprises the article of any one of claims 1-34.

41. A device selected from the group consisting of a slide, plate, film, work surface, well, well plate, Petri dish, tile, jar, flask, beaker, vial, test tube, column, container, cuvette, bottle, drum, vat, tank, and combinations thereof, wherein at least a portion of the device comprises the article of claim 1-34.

42. A device selected from the group consisting of a clamp, skin hook, cuff, retractor, shunt, needle, capillary tube, tubing, and combinations thereof, wherein at least a portion of the device comprises the article of claim 1-34.

43. A device selected from the group consisting of an endotracheal tube, ventilator, associated ventilator tubing, drug delivery vehicle, intrauterine device, syringe, endoscope, and combinations thereof, wherein at least a portion of the device comprises the article of claim 1-34.

44. A device selected from the group consisting of an organ, artificial organ, implant, and combinations thereof, wherein at least a portion of the device comprises the article of claim 1-34.

45. A device selected from the group consisting of a biosensor, diagnostic devices used in and on biological and non-biological material, biological microelectromechanical devices (bioMEMs), bioelectrode, and combinations thereof, wherein at least a portion of the device comprises the article of claim 1-34.

46. A device comprising a wound dressing, wherein at least a portion of the device comprises the article of claim 1-34.

47. A method of preventing, reducing, or delaying adhesion, adsorption, surface- mediated clot formation, or coagulation of a biological material onto a device in contact therewith, comprising: providing the device comprising a low-adhesion surface having a substrate comprising a roughened surface; and a lubricating fluid wetting and adhering to the roughened surface to form a stabilized liquid overlayer, wherein the liquid covers the roughened surface, and wherein the roughened surface and the lubricating liquid have an affinity for each other such that the lubricating liquid is substantially immobilized on the substrate; and

contacting the biological sample to the low-adhesion surface.

48. The method of claim 47, wherein said providing and contacting are carried out to satisfy the following condition y_Bxcos6>Bx - 7AXCOS( AX > 0 (el) wherein ^AX is the interfacial energies of the biological material with a surrounding medium; wherein y_Bx is the interfacial energies of the lubricating fluid with the surrounding medium; wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium; and wherein ΘΒΧ is the equilibrium contact angle of the liquid of the lubricating fluid on a flat solid surface immersed under the surrounding medium.

49. The method of claim 47, wherein said providing and contacting are carried out to satisfy the following two conditions when the slippery surface is exposed to Medium X, where X is air/gas/water/immiscible biological material: ?(yBxCOs6>Bx - 7AXCOS6>AX) - 7AB > 0 (e2) ?(yBxCOs6>Bx - 7AXCOS6>AX) + 7AX - 7BX > 0 (e3) wherein ^AX is the interfacial energies of the biological material with a surrounding medium; wherein }¾x is the interfacial energies of the lubricating fluid with the surrounding medium; wherein }ΆΒ is the interfacial energies of the biological material and the lubricating fluid interface; wherein ΘΑΧ is the equilibrium contact angle of the biological material on a flat solid surface immersed under the surrounding medium; wherein 6½x is the equilibrium contact angle of the lubricating fluid on a flat solid surface immersed under the surrounding medium; wherein the solid substrate is a roughened surface, and

R is a roughness factor of the roughened surface.

50. The method of claim 47, wherein the method inhibits, mediates, or prevents inflammation, wound healing, plaque disposition, or foreign body response.

51. The method of claim 47, wherein the method further prevents, reduces, or delays bacterial contamination.

52. The method of claim 47, wherein the biological material is contacted with the surface at a fluid impact pressures is on the order of 10³-10⁷ Pa.

53. The method of claim 47, wherein the solid substrate is silanized.

54. The method of claim 47, wherein the surface is selected from the group consisting of a cannula, connector, catheter, needle, capillary tube, tubing, syringe and combinations thereof.

55. The method of claim 47, wherein the device is selected from the group consisting of a slide, plate, film, work surface, well, well plate, Petri dish, tile, jar, flask, beaker, vial, test tube, column, container, cuvette, bottle, drum, vat, tank, and combinations thereof.

56. The method of claim 47, wherein the device is selected from the group consisting of a clamp, skin hook, cuff, retractor, shunt, needle, capillary tube, tubing, and combinations thereof.

57. The method of claim 47, wherein the device is selected from the group consisting of an endotracheal tube, ventilator, associated ventilator tubing, drug delivery vehicle, intrauterine device, syringe, endoscope, and combinations thereof.

58. The method of claim 47, wherein the device is selected from the group consisting of an organ, artificial organ, implant, and combinations thereof.

59. The method of claim 47, wherein the device is selected from the group consisting of a biosensor, diagnostic devices used in and on biological and non-biological material, biological microelectromechanical devices (bioMEMs), bioelectrode, and combinations thereof.

60. The method of claim 47, wherein the device is a wound dressing.

61. The method of claim 47, wherein the substrate is preferentially wetted by the lubricating fluid.

62. The method of claim 47, wherein the solid substrate is electrically conductive, non- conductive, magnetic, non-magnetic, elastic, non-elastic, light sensitive, or not light sensitive.

63. The method of claim 47, wherein the lubricating fluid infiltrates the substrate by capillary action.

64. The method of claim 47, wherein the substrate is a roughened surface comprising a porous material.

65. The method of claim 47, wherein microparticles or nanoparticles are applied to a flat substrate to form a roughened, porous substrate.

66. The method of claim 65, wherein microparticles or nanoparticles are applied to the substrate using photolithography, projection lithography, e-beam writing or lithography, depositing nanowire arrays, growing nanostructures on the surface of a substrate, soft lithography, replica molding, solution deposition, solution polymerization,

electropolymerization, electrospinning, electroplating, vapor deposition, layered deposition, rotary jet spinning of polymer nanofibers, contact printing, etching, transfer patterning, microimprinting, self-assembly, boehmite (γ-ΑΙΟ(ΟΗ)) formation, spray coated, and combinations thereof.

67. The method of claim 47, wherein the substrate consists of a fluoropolymer.

68. The method of claim 47, wherein the biological material is selected from the group consisting of a simple aqueous fluid, a complex aqueous fluid, a solidified fluid, and combinations thereof.

69. The method of claim 47, wherein the biological material is a fluid selected from the group consisting of whole blood, plasma, serum, sweat, feces, urine, saliva, tears, vaginal fluid, prostatic fluid, gingival fluid, amniotic fluid, intraocular fluid, cerebrospinal fluid, seminal fluid, sputum, ascites fluid, pus, nasopharengal fluid, wound exudate fluid, aqueous humour, vitreous humour, bile, cerumen, endolymph, perilymph, gastric juice, mucus, peritoneal fluid, pleural fluid, sebum, vomit, and combinations thereof.

70. The method of claim 47, wherein the biological material is a solution or suspension containing bacteria selected from the group consisting of Actinobacillus {e.g. , Actinobacillus actinomycetemcomitans), Acinetobacter (e.g., Acinetobacter baumannii), Aeromonas, Bordetella (e.g., Bordetella pertussis, Bordetella bronchiseptica, and Bordetella

parapertussis), Brevibacillus, Brucella, Bacteroides (e.g., Bacteroides fragilis),

Burkholderia (e.g., Burkholderia cepacia and Burkholderia pseudomallei), Borelia (e.g., Borelia burgdorfen), Bacillus (e.g., Bacillus anthracis and Bacillus subtilis), Campylobacter (e.g., Campylobacter jejuni), Capnocytophaga, Cardiobacterium (e.g., Cardiobacterium hominis), Citrobacter, Clostridium (e.g. , Clostridium tetani or Clostridium difficile), Chlamydia (e.g., Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psiffaci), Eikenella (e.g., Eikenella corrodens), Enterobacter, Escherichia (e.g., Escherichia coli), Francisella (e.g., Francisella tularensis), Fusobacterium, Flavobacterium, Haemophilus (e.g., Haemophilus ducreyi or Haemophilus influenzae), Helicobacter (e.g., Helicobacter pylori), Kingella (e.g., Kingella kingae), Klebsiella (e.g., Klebsiella pneumoniae), Legionella (e.g., Legionella pneumophila), Listeria (e.g., Listeria monocytogenes), Leptospirae, Moraxella (e.g., Moraxella catarrhalis), Morganella, Mycoplasma (e.g. , Mycoplasma hominis and Mycoplasma pneumoniae), Mycobacterium (e.g. , Mycobacterium tuberculosis or Mycobacterium leprae), Neisseria (e.g., Neisseria gonorrhoeae or Neisseria

meningitidis), Pasteurella (e.g., Pasteurella multocida), Proteus (e.g., Proteus vulgaris and Proteus mirablis), Prevotella, Plesiomonas (e.g., Plesiomonas shigelloides), Pseudomonas (e.g., Pseudomonas aeruginosa), Providencia, Rickettsia (e.g., Rickettsia rickettsii and Rickettsia typhi), Stenotrophomonas (e.g. , Stenotrophomonas maltophila), Staphylococcus (e.g., Staphylococcus aureus and Staphylococcus epidermidis), Streptococcus (e.g.,

Streptococcus viridans, Streptococcus pyogenes (group A), Streptococcus agalactiae (group B), Streptococcus bovis, and Streptococcus pneumoniae), Streptomyces (e.g., Streptomyces hygroscopicus), Salmonella (e.g., Salmonella enteriditis, Salmonella typhi, and Salmonella typhimurium), Serratia (e.g., Serratia marcescens), Shigella, Spirillum (e.g., Spirillum minus), Treponema (e.g., Treponema pallidum), Veillonella, Vibrio (e.g., Vibrio cholerae, Vibrio parahaemolyticus, and Vibrio vulnificus), Yersinia (e.g., Yersinia enter ocolitica, Yersinia pestis, and Yersinia pseudotuberculosis), Xanthomonas (e.g., Xanthomonas maltophilia) and combinations thereof.

71. The method of claim 47, wherein the biological material is a solution or suspension containing fungi selected from the group consisting of a member of the genus Aspergillus (e.g., Aspergillus flavus, Aspergillus fumigatus, Aspergillus glaucus, Aspergillus nidulans, Aspergillus niger, and Aspergillus terreus), Blastomyces dermatitidis, Candida (e.g. , Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, and Candida guillermondii), Coccidioides immitis, Cryptococcus (e.g., Cryptococcus neoformans, Cryptococcus albidus, and Cryptococcus laurentii), Histoplasma capsulatum var. capsulatum, Histoplasma capsulatum var. duboisii, Paracoccidioides brasiliensis, Sporothrix schenckii, Absidia corymbifera; Rhizomucor pusillus, Rhizopus arrhizous, and combinations thereof.

72. The method of claim 47, wherein the biological material is a solution or suspension containing viruses selected from the group consisting of cytomegalovirus (CMV), dengue, Epstein-Barr, Hantavirus, human T-cell lymphotropic virus (HTLV I/II), Parvovirus, hepatitides (e.g., hepatitis A, hepatitis B, and hepatitis C), human papillomavirus (HPV), human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), respiratory syncytial virus (RSV), Varicella zoster, West Nile, herpes, polio, smallpox, yellow fever, rhinovirus, coronavirus, Orthomyxoviridae (influenza viruses) {e.g.,

Influenzavirus A, Influenzavirus B, Influenzavirus C, Isavirus and Thogotovirus), and combinations thereof.

73. The method of claim 47, wherein the biological material is a solution or suspension containing particles selected from the group consisting of normal cells, diseased cells, parasitized cells, cancer cells, foreign cells, stem cells, and infected cells, microorganisms, viruses, virus-like particles, bacteria, bacteriophage, proteins, cellular components, cell organelles, cell fragments, cell membranes, cell membrane fragments, viruses, virus-like particles, cytosolic proteins, secreted proteins, signaling molecules, embedded proteins, nucleic acid/protein complexes, nucleic acid precipitants, chromosomes, nuclei,

mitochondria, chloroplasts, flagella, biominerals, protein complexes, and minicells.

74. The method of claim 47 , wherein the biological material is a natural or synthetic solution used in medicines, intravenous solutions, pharmaceutical manufacturing, or medication delivery systems.

75. The method of claim 47, wherein the lubricating fluid is capable of self-healing by wicking back to the damaged region of the substrate after physical damage of the substrate to form an ultra- smooth surface.

76. The method of claim 75, wherein a recovery time for self-healing occurs in less than 50 ms, 60 ms, 70 ms, 80 ms, 90 ms, 100 ms, 110 ms, 120 ms, 130 ms, 140 ms, 150 ms, 160 ms, 170 ms, 180 ms, 190 ms, 200 ms, 210 ms, 220 ms, 230 ms, 240 ms, 250 ms, 1 second, 5 seconds 10 seconds, 30 seconds, 60 seconds, 90 seconds, or 120 seconds or more.

77. The method of claim 47, wherein the substrate has a plurality of holes, three- dimensionally interconnected network of holes and one or more materials, or random array of fibrous materials.

78. The method of claim 47, wherein the substrate consists of a material selected from the group consisting of polymers, metals, sapphire, glass, diamond, graphite, black carbon, or ceramics.

79. The method of claim 47, wherein the substrate is a hemocompatible material.

80. The method of claim 47, wherein the substrate is a polymer selected from the group consisting of polytetrafluoroethylene, polyvinylfluoride, polyvinylidene fluoride, and fluorinated ethylene propylene.

81. The method of claim 47, wherein the lubricating fluid has a density greater than the density of the biological material.

82. The method of claim 47, wherein the lubricating fluid has a density greater than lubricating fluid has a density that is more than 1.0 g/cm³, 1.6 g/cm³, or 1.9 g/cm³.

83. The method of claim 47, wherein the lubricating fluid comprises a fluid selected from the group consisting of tertiary perfluoroalkylamines,perfluorotri-n-butylamine, perfluoroalkylsulfides, perfluoroalkylsulfoxides, perfluoroalkylethers, perfluorocycloethers, perfluoropolyethers, perfluoroalkylphosphines, and perfluoroalkylphosphineoxides, and combinations thereof.

84. An optically transparent device that prevents, reduces, or delays adhesion of biological material, the device comprising:

a roughened surface, wherein the surface is a transparent window;

a lubricating fluid that wets and adheres to the roughened surface to form an over- coated layer; and

wherein the roughened surface has a greater affinity towards the lubricating fluid as compared to a biological material; and wherein the index of refraction of the lubricating liquid is substantially similar to the index of refraction of the roughened surface; and

wherein the lubricating liquid and the biological material are substantially chemically inert with each other.

85. The device of claim 84, wherein the device is a biological sensor window.

86. An article having a low adhesion surface for preventing or reducing biofilm attachment, comprising: a solid substrate having a roughened surface;

a lubricating fluid that adheres to and preferentially wets the substrate to form a liquid upper surface, the liquid upper surface configured and arranged to contact a biological material of interest,

wherein the lubricating fluid is immiscible with the biological material, and wherein the biological material exhibits little or no adhesion to the article.